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Effect of Obesity on the Traditional and Emerging Cardiovascular Disease Risk
Factors in African American Women
Abstract
Background: Obesity is a growing health care concern with cardiovascular disease (CVD) implications.
African American women (AAW) have the highest prevalence rate of obesity and highest CVD morbidity
and mortality rate of all ethnic groups. The traditional CVD risk factors have not been sufficient to explain
this disparity in disease prevalence and outcomes. Current knowledge is limited regarding the interaction
between various levels of adiposity and both traditional and emerging CVD risk factors, particularly in
AAW. This study sought to explore these interactions.
Methods: The study design was a cross-sectional, descriptive, correlational analysis of 48 AAW ages 18
to 45 who had no known history of CVD. Participants completed a demographic/health history
questionnaire and 7-Day Physical Activity Recall Questionnaire. Anthropometric assessment of height,
weight, BMI, waist circumference, and waist-hip-ratio were determined. An average of two resting blood
pressures was taken. Hypertension was defined as a systolic blood pressure ≥ 140 mmHg or diastolic
blood pressure ≥ 90 mmHg. Fasting blood levels were drawn of traditional (glucose, total cholesterol, low
density lipoprotein cholesterol, high density lipoprotein cholesterol, triglycerides) and emerging risk
factors (fibrinogen, high density C-reactive protein [hs-CRP], plasminogen activator inhibitor-1 [PAI-1], Eselectin, quantitative insulin sensitivity check index [QUICKI], and soluble intercellular adhesion
molecule-1 [sICAM-1]). Prediabetes and diabetes were determined based on the American Diabetes
Association criteria. Normal values for lipids were based on Adult Treatment Panel (ATP) III guidelines.
Reference lab norms were used for fibrinogen (< 350 mg/L), hs-CRP (< 2 mg/L), and PAI-1 (< 28 mg/mL).
Normative values for QUICKI, sICAM-1, and E-selectin have not yet been established, thus cut-points used
for these tests were from previous research studies. Analyses included descriptive statistics, t-test, chisquare, and Spearman’s correlation analysis. An alpha level of 0.05 was set a priori for statistical
significance.
Results: Only 4.17% of our participants reported a history of diabetes and hypertension. The most
common traditional risk factor identified was physical inactivity (72.92%), followed by a positive family
history of CVD (58.3%). Obesity, defined as a measured BMI ≥ 30 kg/m2, was present in 56.25%. All of our
participants had insulin resistance, and 56.25% had elevated fibrinogen levels. Our findings indicated that
the obese weight group had a higher systolic blood pressure (p = 0.0002) and diastolic blood pressure (p
= 0.0007), and lower HDL-c (p = 0.01) and higher triglyceride levels (p=0.02) than the normal weight
group. The obese group had significantly higher levels of hs-CRP (p = 0.002) and fibrinogen (p=0.01)
compared to the normal weight groups. Compared to the normal weight group, the obese group had
significantly more CVD risk factors (6.9 vs. 4.1, p < 0.05).
Conclusion: Obesity is associated with a higher prevalence of both the emerging and traditional
cardiovascular risk factors in AAW without a previous history of CVD. Physical inactivity is the most
prevalent modifiable risk factor in this population. Focused intervention on obesity and physical inactivity
could provide substantial reduction in CVD morbidity and mortality among AAW
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ABSTRACT
Background: Obesity is a growing health care concern with cardiovascular disease
(CVD) implications. African American women (AAW) have the highest prevalence rate
of obesity and highest CVD morbidity and mortality rate of all ethnic groups. The
traditional CVD risk factors have not been sufficient to explain this disparity in disease
prevalence and outcomes. Current knowledge is limited regarding the interaction between
various levels of adiposity and both traditional and emerging CVD risk factors,
particularly in AAW. This study sought to explore these interactions.
Methods: The study design was a cross-sectional, descriptive, correlational analysis of
48 AAW ages 18 to 45 who had no known history of CVD. Participants completed a
demographic/health history questionnaire and 7-Day Physical Activity Recall
Questionnaire. Anthropometric assessment of height, weight, BMI, waist circumference,
and waist-hip-ratio were determined. An average of two resting blood pressures was
taken. Hypertension was defined as a systolic blood pressure ≥ 140 mmHg or diastolic
blood pressure ≥ 90 mmHg. Fasting blood levels were drawn of traditional (glucose, total
cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol,
triglycerides) and emerging risk factors (fibrinogen, high density C-reactive protein [hsCRP], plasminogen activator inhibitor-1 [PAI-1], E-selectin, quantitative insulin
sensitivity check index [QUICKI], and soluble intercellular adhesion molecule-1
[sICAM-1]). Prediabetes and diabetes were determined based on the American Diabetes
Association criteria. Normal values for lipids were based on Adult Treatment Panel
(ATP) III guidelines. Reference lab norms were used for fibrinogen (< 350 mg/L), hsCRP (< 2 mg/L), and PAI-1 (< 28 mg/mL). Normative values for QUICKI, sICAM-1,
and E-selectin have not yet been established, thus cut-points used for these tests were
from previous research studies. Analyses included descriptive statistics, t-test, chi-square,
and Spearman’s correlation analysis. An alpha level of 0.05 was set a priori for statistical
significance.
Results: Only 4.17% of our participants reported a history of diabetes and hypertension.
The most common traditional risk factor identified was physical inactivity (72.92%),
followed by a positive family history of CVD (58.3%). Obesity, defined as a measured
BMI ≥ 30 kg/m2, was present in 56.25%. All of our participants had insulin resistance,
and 56.25% had elevated fibrinogen levels. Our findings indicated that the obese weight
group had a higher systolic blood pressure (p = 0.0002) and diastolic blood pressure (p =
0.0007), and lower HDL-c (p = 0.01) and higher triglyceride levels (p=0.02) than the
normal weight group. The obese group had significantly higher levels of hs-CRP (p =
0.002) and fibrinogen (p=0.01) compared to the normal weight groups. Compared to the
normal weight group, the obese group had significantly more CVD risk factors (6.9 vs.
4.1, p < 0.05).
Conclusion: Obesity is associated with a higher prevalence of both the emerging and
traditional cardiovascular risk factors in AAW without a previous history of CVD.
Physical inactivity is the most prevalent modifiable risk factor in this population. Focused
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intervention on obesity and physical inactivity could provide substantial reduction in
CVD morbidity and mortality among AAW.
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CHAPTER 1. INTRODUCTION
Overview
Obesity affects a large proportion of the United States population and has become
a significant public health problem. Among the United States adult population aged 20
years or older, the prevalence of obesity doubled in the last two decades with over one
third of women being obese (American Obesity Association [AOA], 2002). African
American women have the highest rate of obesity compared with other women in the
United States with more than 50% of them disproportionately affected (Flegal, Carroll,
Ogden, & Johnson, 2002). Additionally, at similar levels of adiposity, African American
women have more obesity related diseases compared to other ethnic minorities (Ogden et
al., 2006; Poirier & Eckel, 2002; Rao, Donahue, Pi-Sunyer, & Fuster, 2001). This
increasing obesity prevalence raises concern because of its public health implications.
Obesity is a major cause of preventable deaths in the United States as well as a
potent risk factor for cardiovascular disease with atherosclerotic cardiovascular disease as
its foremost physical consequence (Grundy, Hansen, Smith, Cleeman, & Kahn, 2004).
Obesity affects cardiovascular disease morbidity and mortality mainly by promoting the
occurrence of cardiovascular disease risk factors such as insulin resistance, type 2
diabetes, dyslipidemia, hypertension, and reportedly has an impact on markers of
inflammation, thrombosis, and endothelial function (Poirier & Eckel, 2002).
Racial and ethnic minorities in the United States have a risk of cardiovascular
disease that is at least equivalent to that of the Caucasian majority (Ferdinand, 2006).
African Americans, especially women, have the highest overall cardiovascular disease
mortality of any ethnic group in the United States (Ford, Giles, & Dietz, 2002).
According to the American Obesity Association (2002), African American women have a
higher cardiovascular disease prevalence rate (44.7%) compared to Caucasian women
(32.4%). The reason for this disparity is not well understood. Several risk factors increase
the risk of developing cardiovascular disease. One potential reason for the increased
cardiovascular disease risk in African American women may be the higher prevalence of
obesity which has produced a greater clustering of risk factors known as the metabolic
syndrome in addition to inadequate screening and a lack of evidence-based treatment of
this group in clinical practice (Ferdinand, 2007; Grundy, Hansen, Smith, Jr., Cleeman, &
Kahn, 2004). This makes obesity prevention and management a major public health
concern within this population.
The Framingham Heart Study was the landmark study that identified the currently
accepted risk factors for cardiovascular disease which includes: hypertension, diabetes,
hyperlipidemia, advancing age, gender, physical inactivity, obesity, and a family history
of heart disease (Dawber, Meadors, & Moore Jr., 1951). Even though these traditional
risk factors have served some useful purpose in cardiovascular risk stratification, it is
debatable how generalizable the findings from this study are given the lack of
heterogeneity of the study sample. To bridge this gap, recent clinical studies are
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beginning to include women; notwithstanding, African American women remain grossly
underrepresented in most clinical trials.
It is therefore not surprising that despite improvements in cardiovascular risk
identification, diagnosis, and management, cardiovascular disease remains the leading
cause of death among women in the United States, with African American women
excessively affected. It has been previously accepted that cardiovascular disease occurs
as a result of lipid abnormalities (Goff, Labarthe, Howard, & Russell, 2002; Haffner &
Taegtmeyer, 2003; Ross, 1999). An elevated LDL-cholesterol was found in most people
with high serum cholesterol mainly because much of the serum cholesterol is transported
in LDL-cholesterol. As a result of this association, the evidence suggested that high LDLcholesterol concentrations initiate atherogenesis and promote atherosclerosis. Similarly, a
high HDL-cholesterol level has been described as cardioprotective (Cossrow & Faulkner,
2004). African American women have been shown to have low LDL-cholesterol and high
HDL-cholesterol concentrations (Ferdinand, 2007; Gardner, Winkleby, & Fortmann,
2000; Hall et al., 2006), despite the higher incidence of cardiovascular disease among this
population. Traditional cardiovascular risk factors alone have not been sufficient to
explain the growing rate of cardiovascular disease morbidity and mortality among
African American women (Ridker, Stampfer, & Rifai, 2001; Rifai & Ridker, 2001).
There is currently a growing body of evidence linking inflammation to
atherosclerosis (Danesh et al., 2000; Ross, 1999). Elevation in markers of inflammation,
thrombosis, and endothelial dysfunction (such as hs-CRP, PAI-1, sICAM-1, E-selectin,
QUICKI, and fibrinogen) is thought to predict cardiovascular disease risk and outcomes
in otherwise healthy individuals (Libby & Ridker, 2004). These markers of inflammation,
thrombosis, and endothelial dysfunction, which complement the traditional risk factors,
are now considered the emerging cardiovascular disease risk factors. Their utility in
clinical practice and implication to African American women’s cardiovascular disease
risk stratification is still under investigation.
It is now known that cardiovascular disease starts early in the teenage years but
often does not manifest until women are in their late forties or in the perimenopausal
years (Nguyen & McLaughlin, 2002). Early detection of the risk markers for
cardiovascular disease will no doubt enhance the development of interventions that could
prevent progression of the disease in later years. This research study examined the role of
obesity on the traditional and emerging cardiovascular disease risk factors in African
American women 18 to 45 years of age.
Purpose of the Study
Obesity has reached epidemic proportions in the United States—affecting
approximately 97 million adults (American Heart Association, 2009a). The increased
incidence of cardiovascular disease has been linked directly and indirectly to obesity with
its attendant multiple co-morbidities. Obesity is a major cause of preventable deaths in
the United States and has been classified by the American Heart Association as a major
modifiable risk factor for cardiovascular disease. Billions of dollars in health care costs
2

have been attributed to the rising incidence of obesity, making obesity a major public
health concern (Finkelstein, Fiebelkorn, & Wang, 2004; Flegal, Carroll, Ogden, &
Johnson, 2002). African American women have the highest incidence of obesity of all
women in the United States, and they suffer enormously from the consequences of
obesity-associated diseases. Moreover, there is a paucity of knowledge regarding the
association between obesity and the emerging cardiovascular disease risk factors in
general—and particularly in African American women. This presents an increasing need
for researchers to study the impact of obesity on the traditional and emerging
cardiovascular disease risk factors in this understudied population.
This study seeks to describe the prevalence of the traditional and emerging
cardiovascular disease risk factors in African American women who are 18 to 45 years of
age and to examine the relationship between body mass index (BMI) and the traditional
(diabetes, dyslipidemia, hypertension, physical inactivity) and emerging (hs-CRP, PAI-1,
E-selectin, QUICKI, fibrinogen, sICAM-1) cardiovascular disease risk factors. The
principal hypothesis of this study was that higher BMI is associated with higher levels of
the traditional and emerging cardiovascular disease risk factors.
Aims
This study was guided by specific aims that were derived from the literature. The
following aims were explored in the course of this study:
Specific Aim One
Describe the prevalence of traditional and emerging cardiovascular disease risk
factors in African American women ages 18 to 45 without a known history of
cardiovascular disease.
Specific Aim Two
Examine the relationship between BMI, physical activity levels, and other
traditional (insulin resistance, diabetes, dyslipidemia, hypertension) and emerging (hsCRP, PAI-1, E-selectin, fibrinogen, sICAM-1, insulin resistance [QUICKI])
cardiovascular disease risk factors in African American women.
Specific Aim Three
Compare traditional and emerging cardiovascular disease risk factors among
normal weight and obese African American women.
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Conceptual Framework
Although several conceptual frameworks have been utilized in the literature to
discuss cardio-metabolic issues, the ideas they discussed, though helpful, were not
sufficient to guide the methodological decisions and to aid in the interpretation of our
study results. A conceptual framework is a drawing that brings together the concepts
and/or theories that guide the investigator in the conduct and analysis of a study
(LoBiondo-Wood & Haber, 1990). The conceptual framework in the current study
(Figure 1.1) was developed by the investigators and focuses on the risk factors that
contribute to cardiovascular health and their interactions with each other.
The Framingham Heart Study and other subsequent clinical studies have
identified several modifiable and non-modifiable risk factors that increase the risk of
cardiovascular disease. Modifiable risk factors differ from non-modifiable risk factors
because they can be prevented, treated, or controlled (American Heart Association
[AHA], 2009d). Examples of the modifiable risk factors include tobacco use, high blood
cholesterol, high blood pressure, physical inactivity, obesity, and diabetes mellitus;
increasing age, male gender, and heredity are some non-modifiable risk factors.
Individuals with the non-modifiable risk factors are not only predisposed to
cardiovascular disease but also tend to have more abnormal levels of the modifiable
traditional risk factors.
Recent literature shows that the emerging cardiovascular disease risk factors
independently contribute to cardiovascular disease even in those with normal levels of the
traditional risk factors (Ridker, 2008; Ridker et al., 2008). Additionally, several studies
have also implicated multiple social and cultural factors such as racism, literacy levels,
psychosocial stress, access to health care, socio-economic status, and health belief
systems in the higher prevalence of cardiovascular risk factors among minorities and the
development of cardiovascular disease (Albert, Glynn, Buring, & Ridker, 2006; Griffith,
Moy, Reischl, & Dayton, 2006).
Although the prevalence rate of cardiovascular disease risk factors and mortality
has declined over the past few decades, cardiovascular disease remains the leading cause
of illness, disability, death, and medical costs in the United States (Brownson, Smith,
Jorge, Dean, & DePrima, 1992; Winkleby, Kraemer, Ahn, & Varady, 1998). The
prevalence rates of modifiable cardiovascular disease risk factors such as smoking,
physical inactivity, obesity, dyslipidemia, and hypertension vary across population
subgroups. Previous knowledge indicated that cardiovascular disease risk factors are
highest among males and older individuals. Current literature suggests that younger
African American women do have a clustering of cardiovascular disease risk factors
(Diez-Roux, 1999) and have been shown to experience a higher prevalence of
cardiovascular disease compared to Caucasian women (44.75% vs. 32.4%, respectively).
National data indicates that more women die from coronary heart disease than men, with
African American women having the highest morbidity and mortality rate (AHA, 2006).
Cardiovascular disease risk factors are more prevalent among African American
women. Several studies, such as the Bogalusa Heart Study, the Coronary Artery Risk
4

Socio-cultural factors
• Racism
• Literacy levels
• Psychosocial stress
• Access to health care
• Socio-economic status
• Health belief systems

Emerging CVRF
• Abnormal lipid
metabolism
• Insulin resistance
• Inflammatory markers
(CRP)
• ↑ Homocysteine
• Prothrombotic markers
(fibrinogen, PAI-1)
• Endothelial
dysfunction markers
(E-selectin, sICAM-1)

Traditional CVRF
Modifiable
• Obesity
• Diabetes
• Hypertension
• Hyperlipidemia
• Tobacco use
• Physical inactivity
Non-modifiable
• Advancing age
• Gender
• Genetics
• Ethnicity
• Family history

Cardiovascular
Disease

Figure 1.1 Factors Contributing to Cardiovascular Disease
*CVRF = cardiovascular risk factor; CRP= C-reactive protein; PAI-1 = plasminogen
activator inhibitor-1; sICAM-1 = soluble intercellular activator molecule-1
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Development in Young Adults (CARDIA) Study, the Atherosclerosis Risk in
Communities (ARIC) Study and the Multi-Ethnic Study of Atherosclerosis (MESA), and
most recently the Justification for the Use of Statins in Prevention: An Intervention Trial
Evaluating Rosuvastin (JUPITER) trial have all identified cardiovascular disease risk
factors in African American women across their lifespan (Adeniyi et al., 2002; Lynch,
Liu, Kiefe, & Greenland, 2006; Nasir et al., 2007; Ridker et al., 2008; Srinivasan, Bao,
Wattigney, & Berenson, 1996). Data from the American Heart Association reveals that
33.9 % of African American women ages 18 and older are physically inactive compared
to 21.6% of white females. Similarly, 77.2% of African American women ages 20 and
older are obese, 41.6% have cholesterol abnormalities, while an estimated 45.4% of the
women within this age group have high blood pressure. The same data further indicates
that 17.2% of African American women who are 18 years of age and older smoke
cigarettes further putting them at risk for cardiovascular disease (AHA, 2006).
Socio-cultural factors such as racism, literacy levels, psychosocial stress, access
to health care, socio-economic status, and health belief systems have been reported in the
literature as playing a significant role in cardiovascular risk and outcome. Albert, Glynn,
Buring, and Ridker’s (2006) report indicated that persons of lower socioeconomic status
have greater cardiovascular risk than those of higher socioeconomic status. They further
noted that educated women were less likely to be smokers, had a lower prevalence of
hypertension, diabetes and obesity, and were more likely to participate in vigorous
physical activity than less educated women. Similarly, levels of the emerging risk factors
such as hs-CRP, sICAM-1, fibrinogen, and homocysteine decreased progressively with
increasing education and income categories. Compared to other racial groups, African
American women are least aware of their cholesterol status and the least likely to monitor
their blood pressure levels (Ayanian, Landon, Landrum, Grana, & McNeil, 2002).
Medical racism both in clinical practice and research has created a perennial distrust of
the system that continues to persist till this day (Jacobs, Rolle, Ferrans, Whitaker, &
Warnecke, 2006; LaVeist, Nickerson, & Bowie, 2000). Despite the clearly positive trends
in cardiovascular disease morbidity and mortality, African American women still have
higher mortality rates. Socioeconomic status (SES) greatly influences access to health
services. Studies reveal that attitudes of young African American women toward food,
body image, and physical activity often affect their weight and overall health status
(Yanovski et al., 2000). While the validity of such reports are still being debated, there is
consensus that the structure of the health system affects screening and treatment of
cardiovascular disease risk factors by affecting both clinician and patient behavior
(McSweeney, Lefler, Fischer, Naylor Jr., & Evans, 2007). Persons who are poor,
unemployed, have less education, or live in rural or inner-city communities are more
likely to experience difficulties obtaining and or affording needed care (Blustein &
Weitzman, 1995). African American females are disproportionately represented among
persons of low SES and are more likely to experience problems accessing the health care
system (Philbin et al., 2000).
Previous studies have shown a clustering of cardiovascular disease risk factors
among poor African Americans. There is a high prevalence of hypertension, physical
inactivity, obesity, and smoking among low income African Americans, with education
and income level inversely related to hypertension, smoking, physical inactivity, and
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obesity (Diez-Roux, 1999). Similarly, an elevation in some markers of inflammation such
as CRP has been reported among socioeconomically disadvantaged persons like African
American women (Zhang et al., 2008). Psychosocial work characteristics have been
noted to predict cardiovascular disease risk factors and health functioning in women with
low SES (Chikani, Reding, Gunderson, & McCarty, 2004).
Research into emerging cardiovascular disease risk markers such as C-reactive
protein, fibrinogen, sICAM-1, PAI-1, and E-selectin is growing, though its influence in
clinical practice is still very limited. Homocysteine and abnormal lipid metabolism, while
being identified as emerging risk factors, were not studied in the population of this study
due to previous studies suggesting that these risk factors were less prevalent in African
Americans. Endothelial dysfunction has been identified as an early marker of
cardiovascular disease and has been shown to predict future coronary artery disease
before atherosclerotic changes appear in arteries. Serum markers of endothelial function
such as E-selectin and intercellular adhesion molecule-1 are associated with either
increased mortality from or increased prevalence of cardiovascular disease (Abdu,
Elhadd, Pfeifer, & Clayton, 2001) similar to obesity and diabetes. Thrombus formation
underpins the development of cardiovascular diseases, including acute coronary
syndromes and ischemic stroke. Howes, Keen, Findlay, and Carter (2008) reported that
individuals with type 2 diabetes may have a cluster of hemostatic abnormalities including
elevated levels of plasminogen activator inhibitor-1 (PAI-1) and fibrinogen that
contribute to acute thrombotic events. Elevations in markers of inflammation and
thrombosis, such as high sensitivity C-reactive protein (hs-CRP), soluble intercellular
adhesion molecule-(sICAM-1), homocystein and fibrinogen, are also associated with
increased cardiovascular disease risk. Research has shown that lower levels of physical
activity and higher levels of BMI were independently associated (P for trend < .001) with
adverse levels of nearly all lipid and inflammatory biomarkers (Mora, Lee, Buring, &
Ridker, 2006).
Thus, socio-cultural factors of racism, low SES, low literacy, limited access to
health care, psychosocial stress, and health belief systems provide a milieu conducive to
the development of cardiovascular risk factors. The extent of traditional cardiovascular
risk factors does not explain the greater cardiovascular disease morbidity and mortality
seen in African American women. Within this milieu, these emerging cardiovascular risk
factors, regardless of the presence of traditional cardiovascular risk factors, may provide
a context for the development of cardiovascular disease in African American women.
Definitions of Major Concepts
Cardiovascular Disease
Cardiovascular disease refers to any disease that affects the cardiovascular
system. Most of it results from an atherothrombotic pathologic process in the body’s
arterial beds and is largely preventable through risk factor reduction. Cardiovascular
disease is the leading cause of death in women in the United States. Several risk factors
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that have the greatest impact on the incidence of cardiovascular disease in men and
women have been identified. Risk factors are diseases, physiologic states, biologic
markers, or other identifiable factors associated with increased incidence of
cardiovascular disease. These risk factors are categorized as traditional, emerging, and
other possible factors that increase the risk for cardiovascular disease.
Traditional Risk Factors
Traditional cardiovascular disease risk factors are those risk factors that were
identified through the Framingham Heart Study. The classic risk factors for
cardiovascular disease are hyperlipidemia, diabetes, hypertension, smoking, obesity,
physical inactivity, advancing age, male gender, and family history of coronary artery
disease. These risk factors are further classified into modifiable and non-modifiable risk
factors. The modifiable risk factors refer to those traditional risk factors that can be
prevented or treated while the non-modifiable risk factors are nature-imposed. The
validity of these risk factors in clinical practice is well established.
Emerging Risk Factors
Emerging or novel cardiovascular disease risk factors refer to those markers of
inflammation, thrombosis, and endothelial dysfunction that could assist in cardiovascular
risk stratification for prevention of cardiovascular disease. A growing body of evidence
supports recommendations to test asymptomatic individuals deemed to be at risk for
cardiovascular disease. Various emerging cardiovascular disease risk factors appear to be
important indicators for vascular disease. They include markers of inflammation (high
sensitivity C-reactive protein, insulin sensitivity), thrombosis (Plasminogen Activator
Inhibitor-1, fibrinogen), and endothelial dysfunction (soluble intercellular adhesion
molecule-1, E-selectin). Additionally, insulin resistance, in combination with obesity, has
been suggested as the underlying mechanisms for the clustering of cardiovascular disease
risk factors that have been identified in the metabolic syndrome
National data indicate that African American women have the highest ageadjusted death rate from cardiovascular disease. The underlying basis for this disparity in
cardiovascular disease morbidity and mortality is multifactorial. Although hyperlipidemia
screening and treatment has proven to be one of the most effective strategies for reducing
cardiovascular disease burden in the U.S. population, it often fails to identify a substantial
proportion of persons at high risk for cardiovascular disease-related events. Elevations in
markers of inflammation, thrombosis, and endothelial dysfunction are also associated
with increased risk. Little data is available relating these emerging risk factors with
increased cardiovascular disease risk in racial and ethnic populations. An understanding
of the impact of obesity on these emerging risk factors in African American women will
enhance our understanding of the disparities in disease prevalence and outcome.
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Sociocultural Factors
Sociocultural factors are those societal and environmental factors that affect the
individual and have far reaching consequences in cardiovascular disease risk factors and
cardiovascular disease. They include such factors as racism, socioeconomic status
indicators like education and income levels, psychosocial stress, access to health care,
and health belief systems.
General Definitions
Obesity
Obesity refers to having an abnormally high proportion of body fat—usually 20%
or more over an individual’s ideal body weight (National Institutes of Health, National
Heart, Lung, and Blood Institute, 1998). The National Institute of Health (NIH) has
recommended body mass index (BMI) as a method for determining obesity. BMI
correlates with the amount of total body fat and is calculated as weight in kilograms
divided by height in meters squared. The Centers for Disease Control and Prevention
(CDC, 2007a) and the World Health Organization (WHO, 2004) define obesity in adults
as a body mass index (BMI) of 30 kg/m2 or higher and normal weight as a BMI of 18.5 to
24.9 kg/m2. This study used BMI to classify participants as obese or normal weight.
Physical Activity
Physical activity consists of any movement of the body that results in energy
expenditure (Caspersen, Powell, & Christenson, 1985). This study utilized the physical
activity recommendations of the U.S. Surgeon General. The recommendation is for
people of all ages to engage in a minimum of 30 minutes of moderate physical activity
(such as brisk walking) on most, if not all, days of the week (CDC, 1999). Conversely,
physical inactivity refers to engaging in less than 30 minutes of moderate or more intense
physical activity fewer than 5 days per week. Physical activity levels were quantified
using the Seven-Day Physical Activity Recall (7-Day PAR) Questionnaire. The 7-Day
PAR Questionnaire is a self-report recall instrument to assess physical activity.
Information regarding the duration, intensity, and volume of physical activity engaged in
by the individual is used to calculate total daily energy expenditure. For this study,
physical activity was defined as total daily energy expenditure as measured by the 7-Day
PAR instrument, and physical inactivity was defined as less than 30 minutes of moderate
or greater intensity activity on fewer than 5 days per week.
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Hypertension
Hypertension is often used synonymously with high blood pressure and is a health
condition that occurs when there is elevated pressure in the arteries. Hypertension is a
silent disorder and requires accurate measurement for diagnosis. Hypertension can be
diagnosed using the automatic or auscultatory method of blood pressure measurement
with a properly calibrated and validated instrument in a single clinic visit using two
readings, 5 minutes apart, sitting in a chair with feet on the floor and arm supported at
heart level (Bakris et al., 2007) . The terms systolic pressure and diastolic pressure refer
to the two numbers that measure blood pressure. Systolic pressure measures cardiac
output and refers to the pressure in the arterial system at its highest, while diastolic
pressure measures peripheral resistance and refers to arterial pressure at its lowest
(Onusko, 2003).
The following categories have been established for blood pressure classification
by the Seventh Report of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure (JNC 7, 2003): normal blood pressure
is a systolic blood pressure less than 120 mmHg and diastolic blood pressure less than 80
mmHg. The diagnosis of prehypertension is with a systolic blood pressure of 120-139
mmHg or diastolic blood pressure of 80-90 mmHg. An individual is said to have stage 1
hypertension if he/she has a systolic blood pressure of 140-159 mmHg or a diastolic
blood pressure of 90-99 mmHg. Stage 2 hypertension occurs with a systolic blood
pressure that is ≥ 160 mmHg or a diastolic blood pressure that is ≥ 100 mmHg. This
study classified blood pressure using the above JNC 7 guideline.
Dyslipidemia
For the purposes of this study, atherogenic dyslipidemia was based on the
standard lipid profile, which includes fasting serum levels of total cholesterol,
triglycerides, low-density lipoprotein cholesterol (LDL-c), and high density lipoprotein
cholesterol (HDL-c). Normal values for total cholesterol (< 200 mg/dl, LDL-cholesterol
(< 130 mg/dl), HDL-cholesterol (≥ 50 mg/dl), and triglyceride levels (< 150 mg/dl) are
based on the criteria established by the National Cholesterol Education Program
(Cleeman & Lenfant, 1998).
The lipid profile or cholesterol tests are performed to reveal information about the
types, amount, and distribution of the various types of lipids in the blood stream. An
elevated cholesterol level, or excess cholesterol, is deposited on the inside walls of
arteries in the form of a plaque. Plaque buildup eventually narrows the arteries causing a
condition known as atherosclerosis, which results in cardiovascular disease (Grundy,
1997). Cholesterol and triglycerides levels of study participants were obtained by
measuring the following lipoproteins: (a) high density lipoproteins (HDL), which are
stable and do not stick to artery walls and (b) low density lipoproteins (LDL), which are
unstable and contain more fat and less protein. Unlike HDL, LDL does stick to the cell
lining and inside of artery walls. Our study screened for triglycerides, total cholesterol,
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and LDL and HDL cholesterol. Triglyceride is a type of fat in the blood stream; elevated
levels are also associated with risk for cardiovascular disease.
Diabetes Mellitus and Impaired Glucose Tolerance
Diabetes mellitus is a syndrome characterized by disordered metabolism and
abnormally high blood sugar resulting from insufficient levels of the hormone insulin
(Alberti & Zimmet, 1998). This study will utilize the fasting plasma glucose level of ≥
126 mg/dl as the criteria for the diagnosis of diabetes or the prescribed use of antidiabetic therapy in keeping with the Expert Committee on the Diagnosis and
Classification of Diabetes Mellitus guidelines. Participants with fasting plasma glucose of
100 to 125 mg/dl will be categorized as having pre-diabetes consistent with the American
Diabetes Association (2007) recommendations.
Insulin Resistance
Insulin resistance is a component of several health disorders, most notably
impaired glucose tolerance and type 2 diabetes mellitus. The cells of insulin resistant
individuals are less responsive to the effect of insulin; as a result, higher concentrations
of insulin are needed to promote adequate glucose uptake into the insulin-resistant cells
(Cefalu, 2001). A significantly reduced level of insulin sensitivity is called insulin
resistance. Several methods have been used to evaluate insulin sensitivity. They include:
the Euglycemic Hyperinsulinemic Clamp, frequently sampled intravenous glucose
tolerance test (FSIGT), Minimal Model Analysis, Oral Glucose Tolerance Test (OGTT),
the Homeostasis Model Assessment (HOMA), and the quantitative insulin sensitivity
check index model (QUICKI). This study utilized the QUICKI method, which is defined
by Katz et al. (2000) with the following formula: I/logl0 + log G0 where I0 = fasting
plasma insulin value in (µU/ml) and G0 = fasting plasma glucose value in (mg/dl). The
major advantage of the QUICKI method is that it requires only one blood draw from a
fasting individual.
High Sensitivity C-reactive Protein (Hs-CRP)
C-reactive protein is one of the acute-phase proteins that increase during systemic
inflammation and has been suggested as an additional way to assess cardiovascular
disease risk (Danesh et al., 2000). High sensitivity CRP (hs-CRP) is a more sensitive
CRP test used to determine heart disease risk (American Heart Association, 2009b). HsCRP appears to decrease the synthesis of endothelial nitrous oxide, thus making the
endothelium more prone to injury. The following interpretation of hs-CRP results has
been recommended by the American Heart Association (2009c): An individual with a hsCRP level < 1.0 mg/L has a low risk of developing cardiovascular disease, while an
individual with a hs-CRP level between 1.0 and 3.0 mg/L has an average risk of
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developing heart disease. Individuals with a hs-CRP level > 3.0 mg/L are said to be at
high risk for developing cardiovascular disease.
Fibrinogen
Fibrinogen is an acute phase reactant as well as a plasma protein that plays an
important role in thrombosis. Fibrinogen promotes atherosclerosis and reliably predicts
prospective risk of initial and recurrent coronary heart disease and stroke (Carty et al.,
2008). Fibrinogen degrades into fibrin degradation products, which stimulates smoothmuscle proliferation. Fibrinogen levels appear to be associated with age, body mass,
cigarette smoking, diabetes mellitus, total cholesterol, HDL-cholesterol, and
triglycerides. Values above 350 mg/dl were considered elevated (Di Napoli, Papa, &
Bocola, 2001).
Soluble Intercellular Adhesion Molecule (sICAM-1)
sICAM-1 is a type of intercellular adhesion molecule that presents in low
concentrations in the membranes of leukocytes and endothelial cells, a factor crucial to
atherosclerosis. ICAM-1 can be induced by interleukin-1 and tumor necrosis factor alpha
and is expressed by the vascular endothelium, macrophages, and lymphocytes. ICAM- is
either a transmembrane protein (mICAM-1) or soluble (sICAM-1) and has been reported
in serum, cerebrospinal fluid, and bronchoalveolar lavage (Wu, McGrath, & Death,
2005). Circulating sICAM-1 is a marker of cardiovascular disease progression and plays
a role in the initiation of atherosclerosis. sICAM-1 predicts the risk for cardiovascular
disease or diabetes mellitus in healthy individuals and has been associated with
cardiovascular disease death in women (Jenny, Arnold, Kuller, Tracy, & Psaty, 2007).
E-selectin
Selectins are a family of cell adhesion molecules. There are three subsets of
selectins: E-selectin (in endothelial cells), L-selectin (in leukocytes), and P-selectin (in
platelets and endothelial cells). This paper focused on E-selectin, which is a 115 kDa,
type-1 transmembrane glycoprotein expressed only on endothelial cells and only after
activation by inflammatory cytokines (interleukin-1, tumor necrosis factor alpha) or
endotoxin (Freestone et al., 2005). Several biological markers have been used as
indicators of endothelial dysfunction. Endothelial dysfunction is a key event in
cardiovascular disease (Bonora, 2006). Soluble E-selectin is found in the blood of healthy
individuals and is increased in individuals with cardiovascular disease and diabetes
mellitus.
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Plasminogen Activator Inhibitor-1 (PAI-1)
Plasminogen activator inhibitor-1 is an important component of the
plasminogen/plasmin system, as it is the major physiologic inhibitor of tissue-type and
urokinase-type plasminogen activator (Taeye, Smith, & Vaughan, 2005). PAI-1 is mainly
produced by the endothelium (cells lining blood vessels) but is also secreted by other
tissue types, such as adipose tissue. Elevations in PAI-1 occur in a variety of clinical
situations that are associated with increased risk of ischemic cardiovascular events such
as in obesity and metabolic syndrome (Janand-Delenne et al., 1998). PAI-1 has been
linked to the increased occurrence of thrombosis in patients and plays an important role
in cardiovascular diseases mainly through inhibition of tissue-type plasminogen activator
(Gils, 2006). Angiotensin II increases synthesis of PAI-1 and so accelerates the
development of atherosclerosis.
Age
Age was defined as the length of time a person has lived in years. Age was
determined by participants’ self-report.
African American Woman
African American woman is a term used to describe females who are citizens or
residents of the United States with African ancestry. The participants in this study selfidentified as African American woman.
Tobacco Use
Tobacco use was defined as self-reported current use of tobacco products
including cigarette, cigar, pipe, or spit tobacco.
Family History of Cardiovascular Disease
The participants in this study self-reported whether a first degree relative had been
diagnosed with cardiovascular disease. Specifically, participants identified whether a
family member had ever been diagnosed with a heart attack, stroke, or congestive heart
failure.
Concept Relationships
African American women have the highest incidence of cardiovascular disease
risk factors such as hypertension, obesity, physical inactivity, smoking, diabetes, and
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dyslipidemia when compared with incidences in the Caucasian and Hispanic populations
(Mosca, Ferris, Fabunmi, & Robertson, 2004). These modifiable risk factors were once
thought to be more prevalent in males and aggravated by advancing age. Recent
knowledge suggests that these risk factors are equally prevalent in perimenopausal
women, although the incidence of coronary heart disease in women increases after
menopause (Nguyen & McLaughlin, 2002). Genetic studies, though evolving, suggest a
familial or ethnic inclination to some of these risk factors. Obesity has become a major
epidemic in the United States. Previous studies have reported a relationship between
obesity and risk factors associated with the development of cardiovascular disease
(Folsom et al., 1991). Obese women are four times as likely to develop type 2 diabetes,
hyperlipidemia, hypertension, and cardiovascular disease (AOA, 2002) as normal weight
women. African American women are twice as likely to be obese as Caucasian women
(Flegal et al., 2002). Genetics as a non-modifiable risk factor was not assessed, while age,
gender, and ethnicity were controlled for in the study design.
Several factors have been posited in the literature for the increased incidence of
the traditional and even the emerging cardiovascular disease risk factors in African
American women. African American women are members of an ethnic minority group,
which often predisposes them to poor health status, including the risk factors for
cardiovascular disease. They often have low income and less education, and studies show
that persons of lower socioeconomic status have greater cardiovascular risk than those of
higher socioeconomic status (Albert, Glynn, Buring, & Ridker, 2006). Obesity appears to
have a strong inverse relationship with socioeconomic status among women in the United
States (AOA, 2002). Although sociocultural factors were not the focus of this study, it is
noteworthy that African American women often suffer form psychosocial stress due to
longstanding effects of racism and the prevailing lack of access to health care.
Emerging cardiovascular disease risk factors are those markers of inflammation,
thrombosis, and endothelial dysfunction that show utility for cardiovascular risk
stratification in otherwise healthy persons. Data is limited regarding the impact of these
emerging risk factors on cardiovascular health particularly in African American women.
Available data show that gender, race, smoking, and BMI were associated with elevated
CRP in socioeconomically disadvantaged individuals such as African American women
(Zhang et al., 2008).
Hemostatic factors and endothelial markers are said to play some role in
racial/ethnic differences in cardiovascular disease rates. Elevated concentrations of
haemostatic variables such as fibrinogen and PAI-1 have been found in both overweight
and obese African American and Caucasian women (Perry, Wang, Goldberg, Ross, &
Jackson, 2007). African American women have some of the highest levels of fibrinogen
and E-selectin but among the lowest levels of intercellular adhesion molecule-1 and PAI1, while Caucasians and Hispanics tend to have intermediate levels of these factors and
markers (Lutsey et al., 2006). Similarly, insulin resistance has been associated with
increased cardiovascular risk including dyslipidemia, hypertension, and impaired
fibrinolysis, particularly in nondiabetic persons.
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Significance of the Study
Despite growing awareness and availability of intervention efforts, the prevalence
of obesity is increasing in virtually all populations and age groups worldwide. This
increase is most evident in the United States, with one in four American adults reportedly
obese (AOA, 2002). Data from the National Health and Nutrition Examination Survey
(NHANES III) 1988-1994 and 1999-2000 reported an increase in the prevalence of
obesity across racial and gender groups (National Institutes of Health, National Heart,
Lung, and Blood Institute, 1998). Longitudinal data on the development of obesity
indicates that the risk of higher obesity rates in women has been greatest in African
American women than any other ethnic group (CDC, 2007a). One out of two African
American women is obese representing the highest prevalence of obesity compared with
Mexican and Caucasian American women (McTigue, Garrett, & Popkin, 2002).
The annual estimated cost of obesity in the United States is $117 billion. This
estimate includes $61 billion in direct medical costs for treatment of related diseases plus
$56 billion in indirect costs, such as lost productivity (Finkelstein, Fiebelkorn, & Wang,
2003). Generally speaking, obese persons incur higher healthcare and medication costs
(36% and 77%, respectively) than normal weight individuals. Emerging evidence about
the economic and human costs of obesity has galvanized interest in greater governmental
involvement to regulate private behavior in order to promote public health (Mello,
Studdert, & Brennan, 2006). Obesity has become a major focus of public health law
because of its growing epidemic and devastating consequences (Nestle & Jacobson,
2000) which cause more deaths every year than AIDS, all cancers, and all accidents
combined.
Several studies have documented the association between obesity and
cardiovascular disease. The Framingham data documented that obesity is an independent
risk factor for cardiovascular disease for both sexes (Castelli, 1984). Different patterns of
obesity appear to correlate to cardiovascular disease incidence. The Nurses’ Health Study
showed that higher waist/hip ratio and greater waist circumference, measures of
abdominal adiposity, were associated with increased risk for cardiovascular disease.
Abdominal obesity, when combined with high body mass index, was found to be an
important risk factor for cardiovascular disease mortality (Zhang et al., 2008). However,
minorities were underrepresented in these studies; thus further work is needed to
determine whether these findings can be translated to minority populations.
Current research suggests an association between obesity and the emerging
cardiovascular disease risk factors (Prineas, Folsom, & Kaye, 1993). However,
knowledge is limited regarding the impact of obesity on the risk factors for
cardiovascular disease in African American women. Consequently, this study examined
the association between obesity and the traditional and emerging cardiovascular disease
risk factors in self-identified healthy African American women with no clinically
apparent cardiovascular disease.
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Assumptions
The following assumptions were made for this study:
•

The study participants honestly and conscientiously completed the demographic
and physical activity recall questionnaires.

•

There were little or no variability between the various instruments/equipments
utilized to obtain subject data for this study.

•

Subjects had fasted for 8-10 hours prior to having blood drawn for cardiovascular
disease risk markers. Elevations in certain laboratory results, such as lipid profile
and insulin and glucose levels, may have occurred if subjects did not adhere to the
instructions regarding fasting prior to the blood being drawn.

•

Concepts embedded within the conceptual model were relevant for examining the
relationship between body weight and cardiovascular disease risk factors in
African American women.
Limitations

There are certain inherent limitations to this pilot study. The convenience sample
size was small (N = 48) and subjects were recruited from three cities in the mid-south—a
region known to have one of the highest prevalence rates of obesity in the nation. It is
unclear that this sample was representative of other African American women in the
other regions of the United States and thus findings may not be generalizable.
The 7-Day PAR Questionnaire was utilized to quantify the activity level of
participants. This instrument has an inherent recall bias and is subject to errors of recall
attributable to memory, omission, and intrusion (Giles-Corti et al., 2006; Richardson,
Ainsworth, Jacobs, & Leon, 2001). Moreover, the utilization of a one-week time frame to
evaluate the study participants’ physical activity duration, intensity, and volume may not
be truly representative of their typical activity patterns.
This study utilized the standard, nationally recognized cut-points to define BMI.
The current use of the BMI as the primary index of obesity is not considered optimal,
given the fact that it measures only total body weight rather than the amount of fat. There
is some concern over the accuracy of the BMI for setting obesity standards since it uses a
standard weight against height formula without taking into account whether the weight is
fat or muscle (Vazquez, Duval, Jacobs Jr., & Silventoinen, 2007). Another limitation of
the BMI as a method of assessing weight is that it does not account for the individual’s
body frame, age, gender, race/ethnicity, and nationality. This is because the distribution
of fat may have more impact on the individual’s cardiovascular risk profile regardless of
a “normal” BMI. Likewise, women often have a higher percentage of body fat than men
(Gelber et al., 2008). These limitations notwithstanding, there is, however, no better
universally agreed index for setting obesity standards and monitoring trends in the
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population at this time other than the BMI. Hence it is used in this study with the
understanding of the potential limitations.
Finally, normative values for the emerging risk factors of PAI-1, E-selectin,
sICAM-1, and QUICKI have not yet been established. Values used were from previous
studies. This limitation can lead to threats to internal validity and could potentially
decrease external validity of the study findings.
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CHAPTER 2. REVIEW OF LITERATURE
Introduction
Cardiovascular disease morbidity and mortality are higher among African
American women compared to Caucasian women, yet awareness of the threat posed by
heart disease is low within this population. Lipid abnormality was characterized by the
Framingham Heart Study as the main cause of atherosclerotic disease. African American
women generally have a favorable lipid profile, implying that there could be other
contributing factors as to why they continue to be disproportionately affected by
cardiovascular disease compared to all ethnic groups in the United States. Similarly,
African American women have higher prevalence rates of high blood pressure, obesity,
and physical inactivity than Caucasian women. Obesity is associated with a constellation
of risk factors for cardiovascular disease such as hypertension, type 2 diabetes, C-reactive
protein, and fibrinogen. Increased physical activity has been shown to ameliorate the
levels of these risk factors as well as help to curb the increasing prevalence of
cardiovascular disease. This chapter will present a review of relevant literature on the
traditional and emerging risk factors for cardiovascular disease.
Obesity
Several years ago, obesity was viewed mainly as a lifestyle issue but over the past
four decades, the United States has witnessed an increase in the prevalence of obesity
across every cadre of the population. The problem of obesity is not limited to the United
States; the epidemic is evident throughout the Western world. As a result, the World
Health Organization (WHO) has declared obesity a major public health concern (WHO,
2004). The Third National Health and Nutrition Examination Survey (NHANES III)
tracked obesity rates in the years 1984 to 1992 and 1999 to 2000 and found that obesity
rate had grown from 55.9% to 64.5%. Among United States adults who are 20 years old
or more, an estimated 66.3% are overweight or obese. Women and ethnic minority
populations are disproportionately affected by obesity. About 34% of women in the
United States are classified as obese (Ogden et al., 2006), with one in two African
American women unduly affected.
Measures of Obesity
Obesity refers to an excessive amount of body fat in relation to lean body mass.
Available literature has described several measures of adiposity which includes:
computed tomography [CT] (measures abdominal fat distribution), magnetic resonance
imaging [MRI] (evaluates distribution of abdominal fat), and electrical impedance (quick
method of measuring percentage of body fat). These methods are expensive and
impractical for routine clinical use. Depending on the purpose, most researchers,
endocrinologists and other healthcare professionals utilize the body mass index (BMI),
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waist-hip ratio (WHR), or waist circumference (WC) measures of adiposity (Gelber et al.,
2008).
The BMI is widely accepted by the National Institutes of Health (NIH), Centers
for Disease Control and Prevention (CDC) and the World Health Organization (WHO) as
the primary tool for measuring obesity and is useful for classifying obesity and disease
severity. The BMI measures weight in proportion to height and is calculated with the
formula: weight in kilograms divided by height in meters squared. Obesity is classified
by a BMI of 30 kg/m2 or above. This refers to a body weight that is at least 30 percent
over the ideal weight of a specified height. The BMI was utilized in this study to
categorize adiposity levels. Normal or ideal body weight is represented by a BMI of 18.5
kg/m2 to 24.9 kg/m2. The BMI as a measure of adiposity has been criticized because it
does not take into account the individual’s age, gender, body frame, or ethnic origin
(Vazquez et al., 2007).
Waist circumference measures abdominal fat and has been associated with
increased risk of cardiovascular disease (Lean, Han, & Morrison, 1995). Cardiometabolic
risk clustering sometimes referred to as the metabolic syndrome has been linked to
abdominal adiposity. Significant metabolic abnormalities such as insulin resistance,
hyperinsulinemia, and elevated triglyceride levels as well as an increased incidence of
hypertension, and diabetes have been associated with abdominal obesity. The U.S.
Department of Health and Human Services (2000) reported that overweight or obese
women who have a waist circumference above 35 inches (>88 cm) have a high risk for
hypertension, type 2 diabetes, and cardiovascular disease. Similar risk applies to men
who have a waist circumference measurement above 40 inches (>102 cm). Similarly,
central fat distribution and total body size are equally important determinants of insulin
resistance. Sumner et al. (2008) studied the BMI and waist circumference thresholds in
African Americans that best predict insulin resistance. They reported that in African
Americans, insulin resistance in men was best predicted by a WC ≥ 102 cm or a BMI ≥
30 kg/m2 and in women by a WC ≥ 98 cm or a BMI ≥ 32 kg/m2. Waist circumference
measures the distance around the abdomen. Evidence report from the National Heart
Lung and Blood Institute [NHLBI] (2006) suggests that WC may be a better health
indicator than BMI of 25 kg/m2 to 34.9 kg/m2. For individuals with a BMI above 35
kg/m2, the use of WC for disease risk classification is less pronounced.
Waist-hip-ratio (WHR) is a measure of abdominal adiposity and refers to the ratio
of the circumference of the waist to that of the hips. Several studies suggest that
abdominal adiposity as measured by WHR is an independent risk factor for
cardiovascular disease in men and women (Lapidus et al., 1984; Larsson et al., 1984;
Prineas, Folsom, & Kaye, 1993; Rimm et al., 1995). Individuals with more weight around
their waist are at a higher health risk for diabetes and cardiovascular diseases than those
with more weight around the hip. Women with a WHR ≥ 0.8 often referred to as “apple
shape,” are at an increased health risk of hypertension, diabetes, and cardiovascular
(NHLBI). Women with WHR under 0.8, “pear shape,” have less risk. Similarly, men
with WHR > 1.0 have a greater risk of these conditions.
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The literature indicates that these three measures are useful in adiposity
measurement and health risk stratification, though the BMI has been said to be limited
because it does not account for variation in body fat distribution and abdominal fat mass
which differ across populations (WHO, 2000). WC closely correlates with BMI and
WHR and has been shown to significantly predict risk for cardiovascular disease. Ho et
al. (2001) in their study of a Hong Kong population found that BMI and WC proved most
effective for men while WC and WHR were preferable for women in predicting
cardiovascular disease. There is some debate among researchers regarding which of the
measures of central adiposity had a higher health risk predictive value. While some argue
for the use of WHR, others prefer the WC as a better measure of central adiposity (Hill et
al., 1999; Molarius & Seidell, 1998). Dalton et al., (2003) evaluated the correlation
between WC, WHR, and BMI with cardiovascular disease risk factors in Australian
adults. They concluded that any of these three obesity measures adequately predicted
cardiovascular disease risk factors but WHR was noted to be the most useful measure of
obesity in identifying individuals with cardiovascular disease risk factors.
Obesity and Health
It is well established that the medical complications of obesity affect nearly every
major organ system in the body. Research studies have documented that obesity promotes
the occurrence of risk factors for cardiovascular disease such as hypertension, insulin
resistance, type 2 diabetes, dyslipidemia, proinflammation and prothrombotic states
(Cassano, Rosner, Vokonas, & Weiss, 1992; Despres et al., 1990). By engendering
comorbid conditions, obesity also increases the risk of premature cardiovascular disease
morbidity and mortality.
Obesity through its impact on the cardiovascular system has been associated with
numerous cardiac complications such as coronary heart disease (CHD), heart failure and
sudden death. The American Heart Association (2009c) has described obesity as a major
cause of preventable death and an independent risk factor for cardiovascular disease.
However, the mechanism for increased cardiovascular risk in obesity is still unclear.
Obesity Costs
The obesity epidemic has been expensive to manage either by the public or
private sectors of the economy. Costs stemming from the management of obesity related
diseases have been astronomical. The United States spent about $75 million dollars in
medical costs in 2003 through Medicare and Medicaid benefits for the treatment of
obesity related conditions. The price of coping with obesity goes beyond cost of
healthcare. Burkhauser & Cawley (2008) reported that obesity can lead to low earning
potential, low workforce participation, unfavorable employment outcomes, and increased
utilization of healthcare resources.
Obesity is growing in epidemic proportions in US adults with numerous
comorbidities. As a risk factor for cardiovascular disease, obesity is associated with
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numerous cardiac complications through its impact on the cardiovascular system. When
adipose tissue accumulates in excess amount, it has implications not only in the
individual’s health but also weighs heavily on the healthcare costs. Several tools are used
to measure adiposity but the BMI in spite of its limitations is a universally accepted
measure of adiposity.
Physical Activity
Physical activity includes anything that makes people move their bodies including
household chores, walking, gardening, and dancing (AHA, 2009c). As the prevalence of
obesity and overweight in the United States continues to rise, cardiovascular disease
consequences are expected to concurrently increase as well. To combat these problems,
the United States first launched a national effort in the 1950s to encourage Americans to
lead a more active lifestyle. This effort has continued and in the 1970s the emphasis
shifted to the cardiovascular benefits of vigorous physical activity such as running,
jogging, aerobics, heavy yard work and competitive sport. Physical activity, in
contemporary times, joins the front ranks of essential health objectives which include:
good nutrition, the use of seat belts, and the prevention of adverse health effects of
tobacco (NIH, NHLBI, 1998).
Despite the campaign to engage the public in physical activity, more than 60% of
adults in the United States do not engage in the recommended amount of physical
activity, while an estimated 25% of the adult populations do not engage in any form of
physical activity (CDC, 2007b). Furthermore ethnic differences exist in the prevalence of
physical inactivity. African American women are less physically active than other
population groups (Felton, Boyd, Bartoces, & Tavakoli, 2002). Fifty-five percent of
African American women are physically inactive and perform no leisure time physical
activity (U.S. Department of Health and Human Services, 2002). Consequently, African
American women have the highest rate of being overweight and obese compared to other
groups in the United States with about four out of five African American women
classified as either overweight or obese (CDC, 2007b). The lack of routine physical
activity among African American women places them at risk for negative health
outcomes including type 2 diabetes and cardiovascular disease. Increasing physical
activity has become a formidable public health challenge given the need to prevent
premature death, unnecessary illness and disability, controlling health care costs, and
maintaining a high quality of life with advancing age.
Health benefits appear to be proportional to the amount of activity. Physical
activity decreases with age and is less common among women than men and among those
with lower income and less education. Furthermore, there are racial and ethnic
differences in physical activity rates, particularly among women. According to the U.S.
Department of Health and Human Services, in 2007, five southern states ranked the
lowest in attaining recommended physical activity rates with African Americans being
less likely to achieve physical activity recommendations than Caucasians (CDC, 2008).
Additionally, this report indicated that 34.9% of African Americans in Tennessee were
physically inactive compared to 26.3% of whites. Rates were slightly better in the other
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states (Mississippi: African Americans 26.6% vs, whites 15.4%; Alabama: African
Americans 21.6% vs. whites 16.7%; Louisiana African Americans 29.7% vs. whites
19.1%; and North Carolina: African Americans 19.9% vs. whites 11.3%). Health
consequences of physical inactivity include 13.5 million people with coronary heart
disease, 1.5 million suffer from heart attack in a given year, 250,000 suffer from hip
fractures each year, over 60 million people (a third of the population) are overweight, and
50 million have high blood pressure.
Given the numerous health benefits of physical activity and the apparent hazards
of being inactive, the need for individuals to adopt a physically active lifestyle has been
echoed by all healthcare agencies. Physical inactivity is a serious, nationwide problem.
Its scope poses a public health challenge for reducing the national burden of unnecessary
illness and premature death.
Physical Activity and CVD Risk Factors
There is increasing evidence linking physical activity to numerous health
improvements. A large number of cohort studies have found that physical activity
significantly reduces the risk of cardiovascular disease in the United States. Several
studies (Blair et al., 1998; Lee, Blair, & Jackson, 1999; Stevens, Cai, Evenson, &
Thomas, 2002) have evaluated the relationship between physical activity and BMI with
the risk of cardiovascular disease and concluded that physical activity had a strong
independent association with cardiovascular disease after adjusting for obesity. Blair and
colleagues (1998) noted that increased physical activity predicts lower cardiovascular
disease risk independent of obesity.
Physical activity also decreases insulin resistance and clinical evidence supports
its role in the prevention and management of type 2 diabetes (Knowler et al., 2002;
Tuomilehto et al., 2001). Cardiovascular disease, manifesting as coronary artery disease,
is the leading cause of morbidity and mortality among patients with type 2 diabetes.
There is an inverse relationship between physical activity and insulin resistance which
subsequently leads to the development of type 2 diabetes (Eriksson & Lindgarde, 1996;
Helmrich, Ragland, Leung, & Paffenbarger, 1991). Type 2 diabetes is a costly and
serious disease that affects over eight percent of adults in the United States (Erkelens,
2001). Prevalence of type 2 diabetes continues to rise in the United States with 16 million
people affected annually. An estimated 11.8% of African American women over age 20
are afflicted with type 2 diabetes (CDC, 2007a).
Physical activity also reduces the risk of developing hypertension and is equally
useful in the management of the disease (Bassett, Fitzhugh, Crespo, King, &
McLaughlin, 2002). Increased physical activity improves endothelial nitric oxide release
and insulin mediated vasodilation and substantially lowers elevated blood pressure
(Cleland, Petrie, Ueda, Elliott, & Connell, 1998; Ritz, 2003). Hypertension is an
established risk factor for cardiovascular disease (Castelli, 1984), increased physical
activity helps lower blood pressure levels thereby decreasing the risk of cardiovascular
disease.
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Studies have shown that increased physical activity have profound effects on
improving dyslipidemia and other lipid disorders. Clinical studies involving multiethnic
groups have found a decrease in LDL-cholesterol, VLDL-cholesterol and triglyceride
levels and an increase in HDL-cholesterol levels in individuals who engaged in regular
physical activity (Tran & Weltman, 1985; Wood, Stefanick, Williams, & Haskell, 1991).
The National Cholesterol Education Panel, Adult Treatment Panel III (NCEP ATP III)
(2002) has emphasized that physical activity be introduced to hyperlipidemic patients
because of its benefits. The purpose of promoting physical activity to patients with
hypercholesterolemia is to maintain a healthy body weight, reduce the risk of metabolic
syndrome and independently reduce the risk of cardiovascular disease which is prevalent
in dyslipidemia given its link to atherosclerosis.
Physical Activity and Obesity
Physical activity plays an important role in weight loss and weight maintenance.
Obesity is recognized as a major public health issue given its rising prevalence and
impact on many chronic diseases. Physical inactivity has been blamed for this epidemic.
Obesity causes an increased physical strain on the myocardium as well as other comorbid
conditions which may contribute to cardiovascular disease. Studies reveal that body
weight has a greater influence on diabetes, and physical activity plays a greater role in
cardiovascular disease (Chandrashekhar & Anand, 1991). Simply put, obesity increases
the risk of major chronic diseases such as diabetes and cardiovascular disease while
physical activity reduces that risk. Physical activity has also been found to be useful in
individuals who are physically active and yet obese. A number of studies have evaluated
the relative merits of physical activity and obesity (Blair & Brodney, 1999; Hu et al.,
2001). They found that physical activity lowers the risk of being overweight and obese
and those who are physically active and are overweight and obese have a lower mortality
rate than individuals who were normal weight and sedentary.
Physical activity has several other benefits which include protection against the
development of colon cancer, osteoporosis and depression. Generally speaking, physical
activity has been shown to improve quality of life by promoting general well being.
Despite available information and increased infrastructure, physical activity levels of
most Americans remain low. Increased physical activity is directly related to preventing
disease, premature death and to maintaining a high quality of life.
Types of Physical Activity
There is an emerging consensus among epidemiologists, health professionals and
experts in exercise science that physical activity need not be vigorous for it to improve
health (NIH, NHLBI, 1998). This notion emphasizes the amount rather than the intensity
of physical activity making it easier to incorporate into daily lives. Daily activities such
as brisk walks, lawn mowing and other household chores that adapt to the individuals
lifestyle are sustainable. The U.S. Department of Health and Human Services (CDC,
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2007b) recommendations for physical activity includes moderate-intensity activities of at
least 30 minutes per day, 5 or more days per week; or vigorous-intensity activities for at
least 20 minutes per day, at least 3 days per week or both. Anything less than these
recommended levels of daily physical activity amounts to physical inactivity.
Physical Activity Measures
The World Health Organization (WHO, 2004) had recommended that energy
requirements be based on the assessments of energy expenditure rather than energy
intake. The challenge posed by this proposal was due to the difficulty associated with
measuring physical activity, a variable component of total energy expenditure, because of
the potential to overestimate or underestimate physical activity levels. Several techniques
have been developed for use in measuring physical activity such as doubly-labeled water
method (DLW), heart rate monitoring, accelerometers, and physical activity
questionnaires.
Assessment Techniques
Doubly-labeled Water
Doubly-labeled water (DLW) technique was developed in the 1950s by Nathan
Lifson (Visser, Boon, & Meijer, 2000). This method involves taking a load of water
labeled with deuterium and oxygen-18 (O-18 or 18O). The deuterium washes out of the
body as water while the 18O washes out of the body as water and carbon dioxide. The
difference between the two elimination rates is a measure of carbon dioxide output
(Schoeller, 1988). Energy expenditure is then calculated from the carbon dioxide using
standard equations. DLW may be administered by injection or orally. The loss of
deuterium and 18O in the subject is tracked by sampling the saliva, urine, or blood
(Schoeller, Taylor, & Shay, 1995). The reliability and validity of this instrument has long
been established. This technique is very useful for measuring metabolic rates over a long
period of time. It has been used extensively in animals and humans including infants and
pregnant women. DLW is regarded as the gold standard for measuring energy
expenditure under living conditions. This method is however expensive and requires
technical expertise.
Accelerometers
Accelerometers are devices used to measure acceleration and the impact of
gravity on the acceleration (Westerterp, 1999). Accelerometers are widely accepted as a
physical activity measure because it offers an objective measurement and is equally
inexpensive (Meijer, Westerterp, Verhoeven, Koper, & ten Hoor, 1991). The
accelerometer is not burdensome on the individual and is able to assess the intensity and
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duration of movement. There are two basic forms of accelerometers those that measure
acceleration in three dimensions (triaxial) and those that measure acceleration in one
dimension (uniaxial). Accelerometers are typically placed at the pelvic girdle and are
capable of monitoring, storing and downloading data for relatively small time intervals
over long period of time to capture the net forces acting on the whole body (Westerterp,
1999). Accelerometers have the capability to assess the intensity of physical activity as
well as to detect vertical movement. Pedometers are unlikely to do both. Examples of
uniaxial accelerometers include the Computer Science and Applications (CSA) and
Actigraph while triaxial accelerometers include Triatrac-R3D, and Tracmor. The validity
and reliability of some of these models are well established. Validation studies have
yielded correlations ranging r = 0.25 - 0.91, for CSA r = 0.89, for Tracmor r = 0.89, for
Actigraph r = 0.46 - 0.73 (Wong, Webster, Montoye, & Washburn, 1981). Although
accelerators are well accepted as a technique for measuring energy expenditure, some fall
backs have been reported such as inability to record static movement, lack of sensitivity
to incline and to changes involving resistances.
Heart Rate Monitor
Heart rate monitor is a device that allows the user to measure their heart rate. An
increase in heart rate is reflective of an increase in the intensity of physical activity. This
can be affected by varying emotional states and environmental stimuli. The heart rate can
also be monitored by checking the radial or carotid pulse using two fingers of one hand to
locate the artery. Accurate pulse count is essential. Heart rate monitoring (not amount of
perspiration produced) is usually the preferred way to monitor the intensity of physical
activity given that there is a range that is safe and effective for promoting cardiovascular
benefits (American Council on Exercise [ACE], 2001). To determine this range, the
individual would have to estimate their maximal heart rate by subtracting their age from
the number 220. This number will guide them to determine the number of beats per
minute at which their heart should be beating during aerobic exercise. For most healthy
individuals, this range is 50% to 80% of their maximal heart rate often referred to as the
target heart rate zone. These numbers then serve as guidelines on the intensity of physical
activity the individual should engage in.
Physical Activity Questionnaires, Recalls, and Records
Another common technique for assessing an individual’s energy expenditure is
physical activity record keeping in a diary. This is a self-report instrument that details
patterns of physical activity performed by the individual. This method is cost effective;
however, its greatest limitation is the demand it places on the individual and the burden it
places on study staff that have to sort through large volumes of information. Recalls
usually adopt an interview format and are useful to assess physical activity over a given
period of time. The limitation of this technique lies in the ability of the individual to
remember and report physical activity patterns with accuracy. Questionnaires are used to
determine the frequency, intensity, duration, context, and type of activity performed by

25

the participant. Although questionnaires may limit the individual’s ability to give detailed
information, their utility in physical activity assessment is well established. The 7-Day
PAR Questionnaire is an example of a tool that utilizes this technique.
Seven-Day Physical Activity Recall Questionnaire
The Seven-Day Physical Activity Recall (7-Day PAR) Questionnaire assesses the
individual’s habitual physical activity pattern utilizing a one-week time frame (Blair et
al., 1998; Sallis et al., 1985). This self-report instrument utilizes both the recall and
questionnaire format to obtain information from the participant. The PAR has shown
utility in exercise, epidemiological studies and a variety of scientific applications through
the information it provides regarding activity volume, intensity, and duration.
To facilitate recall, the instrument is broken down into segments of morning,
afternoon, and evening, and for each segment the participant is asked to report the
amount in minutes of categories of moderate, hard, and very hard activity they
performed. They can only report activities that took not less than 10 minutes to perform.
The time spent sleeping is classified as “light activity.” The PAR is scored by averaging
the number of minutes spent in moderate, hard, and very hard activities. The time spent in
each category is further multiplied by body weight and a caloric value to yield the total
daily energy expenditure. The total energy expenditure is estimated by multiplying each
category by an established metabolic equivalent, or MET value. For instance, sleep = 1
MET, light activity = 1.5 MET, moderate activity = 4 METs, hard activity = 6 METs, and
very hard activity = 10 METs.
The validity and reliability of the 7-Day PAR instrument within the adult
population has been long established. Johnson-Kozlow, Rock, Gilpin, Hollenbach, and
Pierce (2007) found that the Women’s Health initiative had comparable validity,
sensitivity, and measurement bias compared to the widely accepted PAR (correlation =
0.73). Similarly, the validity of the Stanford 7-Day PAR in young adults was evaluated
by Washburn, Jacobsen, Sonko, Hill, and Donnelly (2003). They noted no significant
differences between the 7-Day PAR and the doubly-labeled water technique.
Daily physical activity has tremendous health benefits throughout a lifespan.
Besides its impact in weight reduction, sustained physical activity enhances
cardiovascular health in many ways, including improving endothelial function, improving
lipid profile, and reducing the effects of obesity, diabetes, and hypertension. Physical
activity benefits extend to both normal weight and obese persons irrespective of ethnicity.
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Traditional Cardiovascular Disease Risk Factors
Historical Perspective
Several years ago, high blood pressure was thought to be a normal part of the
aging process and clinicians accepted the notion that atherosclerosis was inevitable.
During those times, most clinicians were unaware of the association between
hypercholesterolemia and heart attacks, and the concepts of risk stratification or
modification of risk factors for cardiovascular disease were unknown. It was over half a
century ago, when the Framingham Heart Study was conducted in Framingham,
Massachusetts, that remarkable advances began in the prevention of cardiovascular
disease not only in the United States but around the world. The Framingham Heart Study
was a large scale public health service investigation examining why heart disease had
become the leading cause of death in the 1940s. The quest to learn the biologic and
environmental factors contributing to cardiovascular disability and death gave rise to the
epidemiological study that was the Framingham Heart Study (Wilson et al., 1998).
The Framingham Heart Study
The first cohort of participants was 5,209 healthy male and female residents
between 30 and 60 years of age from the town of Framingham. Later, in the early 1970s,
children and their spouses from the original cohort group (5,124 persons) were recruited
for a second study, the “Offspring Study” (Rutter, Meigs, Sullivan, D'Agostino, &
Wilson, 2004). Currently, about 500 members of the minority community at Framingham
are being recruited for the “Omni Study” to see if these latest participants have similar or
different risk factors associated with cardiovascular disease when compared with the
other two cohorts, since participants in the original study were mostly white males.
Needless to say, the Framingham Heart Study was the landmark study that first
identified the major risk factors for cardiovascular disease (Dawber, Meadors, & Moore
Jr., 1951). The study established the relationship between the levels of cholesterol and
risk of disease. It further established a strong, positive association of LDL-cholesterol
with cardiovascular disease as well as a powerful inverse and protective effect of HDLcholesterol levels.
Prior to the Framingham Heart Study, there was a widely held notion that women
and the elderly tolerated higher blood pressures well. The study found no justification
that the elderly coped better with hypertension than younger persons; neither did it find
gender differences in cardiovascular disease risk in the presence of high blood pressure.
The study further established the association between cholesterol levels, high blood
pressure, diabetes, and heart disease. The Framingham Study also looked at lifestyle
issues that contributed to the high rates of cardiovascular disease. The study researchers
found that a lifestyle characterized by sedentary behavior, unhealthy diet, and
uncontrolled weight gain exacerbated the risk factors leading to adverse cardiovascular
conditions. The Framingham Heart Study identified high blood pressure, high blood
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cholesterol, smoking, obesity, diabetes, and physical inactivity as the major risk factors
for cardiovascular disease (Wilson, D'Agostino, Sullivan, Parise, & Kannel, 2002). The
role of associated factors such as blood triglyceride, HDL-cholesterol, age, gender, and
psychosocial issues was also highlighted.
The findings of the Framingham Heart Study have been validated in multiple
clinical trials both in the United States and other countries around the world. The
VERIFICA Study of Spain assessed the reliability and accuracy of the Framingham
coronary heart disease risk prediction model and determined that it reliably predicted the
5-year coronary heart disease risk for patients aged 35 to 74 years in their population
(Marrugat et al., 2007). Likewise, Japanese investigators used the Framingham risk
model to accurately evaluate more than 5,000 male subjects and confirmed that it
provided useful information on future coronary heart disease events in Japanese men
(Suka, Sugimori, & Yoshida, 2002). Other investigators, such as D'Agostino, Grundy,
Sullivan, and Wilson (2001), evaluated the applicability of the Framingham risk model to
multiple ethnic groups in six different prospective studies and confirmed that it was
applicable to other ethnic groups after recalibration for differences in the prevalence of
risk factors and underlying rates of coronary heart disease events.
The Framingham Heart Study has been helpful in identifying traditional
cardiovascular risk factors; studies such as the Jackson Heart Study (JHS) have
confirmed its utility in African Americans also (Taylor et al., 2008). The JHS found that
40% of African American women, as opposed to 29% of African American men, had the
traditional cardiovascular risk factors (Association of American Medical Colleges
[AAMC], 2008). The JHS study was an outgrowth of the Atherosclerosis Risk in
Communities (ARIC) study, which is an ongoing all-African American study of men and
women ages 35 to 84 that seeks to investigate the causes of cardiovascular disease in
African Americans in order to learn how to best prevent this group of diseases in the
future. To the best of our knowledge, the findings of this study are yet to be published,
though information about the study’s methodology is discussed in available literature.
Our study’s strength lies in its population, age, and the novelty of our topic of
investigation.
African American women continue to bear a disproportionate burden of
cardiovascular disease mortality and morbidity despite increased awareness of
cardiovascular risk and growing intervention efforts. While hypertension is more
prevalent among African Americans, at similar levels of adiposity, African Americans
have a more protective lipid profile than Caucasians (Kullo, Jan, Bailey, Mosley, &
Turner, 2007). It has become obvious that the traditional cardiovascular disease risk
factors (hypertension, dyslipidemia, diabetes, smoking, and physical inactivity) are
inadequate to explain the increased incidence of cardiovascular disease in African
American women.
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Emerging Cardiovascular Disease Risk Factors
Overview
Although the Framingham coronary risk score has facilitated the identification of
individuals at high risk for cardiovascular disease, researchers now argue that the
classical risk factors used in these algorithms do not adequately differentiate individuals
at moderate risk (Ferns, 2008). The death toll from atherosclerotic cardiovascular disease
continues to rise (WHO, 2004) despite major advances in treatment of ischemic heart
disease. Unfortunately, a large number of victims of the disease who are apparently
healthy die suddenly without prior symptoms (Kanjilal et al., 2008). Available screening
and diagnostic methods are insufficient to identify the victims before the event occurs.
Current knowledge portend that atherosclerosis is not only a lipid disorder but an
inflammatory one as well (Libby, Ridker, & Maseri, 2002). The additional use of
inflammatory biomarkers such as high sensitivity C-reactive protein (hs-CRP),
Plasminogen Activator Inhibitor-1 (PAI-1), soluble Intercellular Adhesion Molecule-1
(ICAM-1), E-selectin, QUICKI, and fibrinogen can improve methods of global
cardiovascular risk assessment (Albert & Ridker, 2006).
Emerging CVD Risk Markers
Several investigators have examined the utility of these emerging markers in
cardiovascular disease stratification. Mora, Rifai, Buring, & Ridker (2006) studied
associations of baseline immunoassay fibrinogen and hs-CRP measurements with
incident cardiovascular disease. This prospective study of almost 28,000 initially healthy
women who were followed for 10 years found that baseline fibrinogen level provides
additive value to hs-CRP and traditional risk factors in predicting incident cardiovascular
disease. Similarly, Smith et al. (2005) followed over 2,000 men for a median of 13 years
to see whether hemostatic markers contribute to risk of coronary disease and ischemic
stroke independently of conventional risk factors. Univariate analysis revealed that
fibrinogen, hs-CRP, D-dimer, tissue plasminogen activator (tPA) and plasminogen
activator inhibitor-1(PAI-1) were associated significantly with risk of cardiovascular
disease while factor VIIc showed an inverse association (p = 0.001).
Another study examined cross-sectional relationships between the concentrations
of soluble adhesion molecules (sICAM-1, sVCAM-1, sP-selectin, and sE-selectin) and
smoking behavior, body composition, blood pressure, serum lipids, and physical activity
in a large sample of about 600 healthy men and women, with special emphasis on
interactions between smoking and other cardiovascular disease risk factors (Demerath,
Towne, Blangero, & Siervogel, 2001). The findings indicated no gender differences in
the concentrations of sICAM-1, sVCAM-1, and sP-selectin, but men had higher sEselectin levels than women (p < 0.0001). Male and female smokers had higher sICAM- 1
and sE-selectin levels than non-smokers, and soluble cell adhesion molecules (CAMs)
were correlated with pack-years of cigarette smoking (r = 0.3 – 0.4, p < 0.0001,
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significant in women only). Significant independent associations were found between
soluble CAMs and smoking, waist-hip-ratio (WHR), blood pressure, HDL-cholesterol,
and total cholesterol. This result showed that concentration of soluble CAMs, particularly
sICAM-1 and sE-selectin, reflect the level of established cardiovascular disease risk
factors in apparently healthy men and women, thus adding to the evidence that these
factors contribute to cardiovascular disease through their inflammatory effects on the
vascular endothelium.
Ridker, Hennekens, Buring, & Rifai (2000) conducted a prospective case-control
study among over 28,000 apparently healthy postmenopausal women. These subjects
were followed for about 3 years to assess the risk of cardiovascular events associated
with base-line levels of hs-CRP, serum amyloid A, interleukin-6, and soluble intercellular
adhesion molecule-1 (sICAM-1), all markers of inflammation. The results indicated that
hs-CRP was the strongest univariate predictor of the risk of cardiovascular events. Other
markers significantly associated with the risk of cardiovascular events were serum
amyloid A, sICAM-1, and interleukin-6. They also noted that prediction models that
incorporated markers of inflammation in addition to lipids were significantly better at
predicting risk than models based on lipid levels alone (p < 0.001).
Thus, these emerging risk factors may play a role in the racial/ethnic differences
in cardiovascular disease rates. Elevated concentrations of hemostatic variables such as
fibrinogen and PAI-1 have been found in both African American and Caucasian
overweight/obese women (Perry et al., 2007). African American women have some of
the highest levels of fibrinogen and E-selectin but among the lowest levels of intercellular
adhesion molecule-1 and PAI-1, while Caucasians and Hispanics tended to have
intermediate levels of these factors and markers. Similarly, insulin resistance has been
associated with increased cardiovascular risk, including dyslipidemia, hypertension, and
impaired fibrinolysis—particularly in nondiabetic persons. Additionally, a multiethnic
study of adults (Howard et al., 1998) found greater insulin resistance was associated with
lipid abnormalities, including elevated LDL and low HDL cholesterol, as well as LDL
size and higher triglycerides. It is recognized that obesity is associated with higher insulin
levels and greater insulin resistance regardless of race (Gower, 1999). However, racial
differences in hyperinsulinemia and insulin resistance are present independent of
adiposity (Velasquez-Mieyer et al., 2000). Lean and obese African Americans exhibiting
higher fasting and stimulated insulin levels than Caucasians (Dowling, Fried, & PiSunyer, 1995; Haffner et al., 1996; Jiang, Srinivasan, Radhakrishnamurthy, Dalferes, &
Berenson, 1996) and greater insulin resistance (Arslanian, Suprasongsin, & Janosky,
1997). These higher insulin levels and greater insulin resistance may be underlying
mechanisms for the higher morbidity and mortality seen in African Americans.
Literature is still sparse regarding the role of inflammation in concert with obesity
in predicting cardiovascular risk in African American women. The POWIRS (Profiles of
Obese Women with the Insulin Resistance Syndrome) Study of South Africa examined
the relationship between inflammation, obesity, and cardiovascular disease in apparently
healthy African and Caucasian women (Schutte et al., 2005). The results showed that the
levels of leptin, hs-CRP, and fibrinogen were significantly higher (p < 0.05) in African
American women. However, except for leptin levels, no other cardiovascular parameters
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explained the variation in the inflammatory markers. There is a growing need to examine
the role of these emerging markers in African American women.
Summary
The United States and many other countries are experiencing an epidemic of
obesity. Physical inactivity, which is more prevalent in women and ethnic minority
population’s particularly African American women, and poor nutrition have been some of
the reasons behind the weight gain. Epidemiological studies have documented a strong
associated between obesity and traditional cardiovascular disease risk factors (Freedman,
Khan, Serdula, Galuska, & Dietz, 2002; Nasir et al., 2007). In recent years, literature has
begun to accumulate regarding the role of inflammation in atherosclerosis formerly
thought to be a lipid disease. Compelling evidence for the importance of inflammation in
atherosclerosis has continued to evolve. Cross-sectional studies have reported
associations between obesity and different inflammatory markers (Festa et al., 2001;
Ford, 1999; Yudkin, Stehouwer, Emeis, & Coppack, 1999). It is possible that the relation
between inflammation and incidence of cardiovascular diseases is mediated through an
increased incidence of the traditional risk factors. However, there is a paucity of data
regarding the impact of obesity on traditional and emerging risk factors for
cardiovascular disease in African American women. This pilot study will provide insight
into the relationship between obesity and cardiovascular disease risk factors in this at-risk
group of women.
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CHAPTER 3. METHODOLOGY
There is an increasing body of evidence that the traditional cardiovascular disease
risk factors alone are inadequate to explain the high rate of cardiovascular disease
morbidity and mortality among African American women (Libby et al., 2002; Ridker,
Hennekens, Buring, & Rifai, 2000). Current research suggests that inflammatory,
thrombotic, and endothelial dysfunction markers such as high sensitivity C-reactive
protein (hs-CRP), plasminogen activator inhibitor-1 (PAI-1), fibrinogen, soluble
intercellular adhesion molecule-1 (sICAM-1), and E-selectin may provide additional
prognostic information about risk of future coronary events in apparently healthy subjects
(Ridker, 1999; Ross, 1999) . This chapter presents a description of the research design,
sample and setting, instruments, procedures, statistical analyses, and human subject
considerations used in this study.
Research Design
This study utilized a cross-sectional, descriptive, correlational design to examine
the impact of obesity on the traditional and emerging cardiovascular disease risk factors
in adult African American women. A cross-sectional design was employed in the current
study because it provides information about lifestyle practices and to examine the
relationships among study variables, such as physical activity levels, illicit drug use,
smoking habits, age, education, marital status, and income levels of a select group of
African American women. The correlational design was used to describe the direction
and magnitude of the relationship between body weight and cardiovascular disease risk
factors. Descriptive statistics were used to describe the basic features of the data in this
study. Burns (1993) noted that correlational studies examine relationships between
variables; thus, statistical correlational methods were used to examine the relationships
that existed between the independent variables (obesity and normal weight) and
dependent variables (traditional and emerging cardiovascular disease risk factors) in
African American women. Traditional cardiovascular disease risk factors examined
included hypertension, diabetes mellitus, family history of cardiovascular disease,
tobacco use, physical inactivity, and dyslipidemia. Fasting blood draws were performed
to check levels of the following emerging risk factors: QUICKI, hs-CRP, PAI-1,
fibrinogen, sICAM-1, and E-selectin.
Sample and Setting
A non-probability, convenience sample of 50 African American women who met
the inclusion criteria were recruited for participation in the study. Since this was an
exploratory study that does not usually lend itself to a power analysis, a sample size of 50
was deemed adequate. Two of the subjects did not complete all study procedures and
were excluded from the analysis. Recruitment of subjects for the study was conducted
from three urban geographic locations in the southern region of the United States. The
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subjects were recruited from mid-south family practice/internal medicine clinics and
Health Works, a program designed to transition women off welfare into the workforce.
The data collection sites included Mississippi, middle Tennessee, and west Tennessee.
The study participants were healthy African American women who self-reported that
they had no known cardiovascular disease. Participants were classified as obese or
normal weight based on their BMI (Figure 3.1).
Inclusion Criteria
The following inclusion and exclusion criteria were established to identify
subjects for this investigation.






Self-identify as African American woman
18 to 45 years of age at the time of enrollment
Body mass index (BMI) of 18.5 to 24.9 kg/m2 for the normal weight category
or a BMI ≥ 30 kg/m2 for the obese category
Able to read and write in English language
Sign informed consent form prior to participation

Exclusion Criteria






Pregnancy
Use of hormone replacement therapy, steroids, and/or cholesterol lowering
medications such as statins
Personal history of gastric bypass surgery
Personal history of cardiovascular disease including coronary artery disease
(CAD), myocardial infarction (MI), congestive heart failure (CHF), and
cerebrovascular accident (CVA)
Inability or unwillingness to give written informed consent

Study Population

Normal Weight
n = 21

Obese
n = 27

Figure 3.1 Study Sample
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Instruments
Measurements of traditional and emerging risk factors were obtained at the same
study visit. Additionally, subjects completed a demographic questionnaire which was
used to characterize the sample.
Urine Pregnancy Test
A urine pregnancy test was performed to determine eligibility for the study.
Individuals with a positive pregnancy test were not eligible to participate in the study;
hence no further study measures were performed. The urine pregnancy test determines
the presence of human chorionic gonadotropin (hCG) hormone in early pregnancy urines
(Wilcox, Baird, Dunson, McChesney, & Weinberg, 2001). The Natureplex Be Certain
Home Pregnancy Test (Memphis, TN), an over-the-counter home pregnancy testing
device that claims > 99% diagnostic accuracy for pregnancy and utility on the first day of
the missed menses or earlier, was used for the study. Participants were instructed to
collect their urine samples in a clean labeled container for easy identification. Three
drops of urine sample were put into the sample well and the unit was laid flat and read
within 5 minutes. The presence of only one pink color control band within the test means
that the individual was not pregnant, while the presence of two pink control and test
bands within the test means that the individual was likely to be pregnant and should
consult her primary care provider. The significance of eliminating pregnant women from
the study lies in the fact that recent studies have documented associations among
pregnancy, obesity, and cardiovascular disease risk markers. Pregnancy has been noted to
increase the levels of the inflammatory markers such as C-reactive protein and fibrinogen
(Ridker, Hennekens, Buring, & Rifai, 2000). Similarly, serum levels of total cholesterol,
HDL-cholesterol, LDL-cholesterol and triglycerides have been noted to increase
substantially by the third trimester (Glew et al., 2004).
Demographic Questionnaire
The participants completed an investigator-developed questionnaire on health
history and issues related to cardiovascular disease (Appendix A). This instrument was
written at a 6th grade reading level and had a multiple-choice response format. Various
demographic variables were assessed, including age in years, marital status, education
level classified by degree earned, income level, history of chronic diseases, medication
and social history, illicit drug use, and history of gastric bypass. All were classified by
yes/no based on self-report. The demographic variables were analyzed using descriptive
statistics. Additionally, tobacco use and family history of cardiovascular disease, two of
the traditional cardiovascular risk factors, were ascertained through self-report on the
demographic questionnaire.
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Seven-Day Physical Activity Recall Questionnaire
The Seven-Day Physical Activity Recall (7-Day PAR) Questionnaire was
developed over two decades ago as a general-purpose measure of physical activity (Sallis
et al., 1985; Appendix B). This self-report recall instrument was used in this study to
assess respondent’s physical activity level and can be completed in about 20 minutes.
This instrument provides detail regarding the intensity, time (duration), and type of
physical activity in a one-week time frame.
The 7-Day PAR instrument breaks down the day into three segments: morning,
afternoon, and evening to facilitate recall. Research subjects were asked to report the
number of hours they spent sleeping and the remaining time is grouped as “light”
activities. They were also asked to report the amount of moderate, hard, and very hard
activity that they performed in the last seven days. The different activity levels were
assigned Metabolic Equivalent (MET) values. Time spent in sleep (1 MET), “light”
activities (1.5 METs), moderate (3 METs), hard (6 METs), and very hard (9 METs)
activities for the past 7 days were multiplied by their respective MET values. The
estimate of the total kilocalories (kcal) of energy expenditure per day is calculated by
multiplying the total METs by the individual weight in kilograms and divided by seven
(number of days) and the result was expressed as kcal/kg/d. Additionally, the number of
days per week individuals self-reported engaging in 30 minutes or more of at least
moderate physical activity was assessed. The validity and reliability of the 7-Day PAR
instrument within multi-ethnic adult population has been long established. JohnsonKozlow, Rock, Gilpin, Hollebenk, and Pierce (2007) found that the Women’s Health
Initiative had comparable validity, sensitivity and measurement bias compared to the
widely accepted PAR (r = 0.73). Similarly, the validity of the Stanford 7-Day PAR in
young adults was evaluated by Washburn, Jacobsen, Sonko, Hill, and Donnelly (2003).
They noted no significant differences between the 7-Day PAR and the doubly-labeled
water group. Ainsworth et al. (2000) analyzed the physical activity patterns of 141
African American and Native American women, ages 40 and older, enrolled in the CrossCultural Activity Participation Study. Using the 7-Day PAR instrument, they found that
physical activity participation patterns differed by ethnicity, with relatively more Native
American women reporting moderate intensity walking for exercise, occupational
activities and child care activities compared with African American women (p < 0.05).
Blood Pressure and Heart Rate Screening
The study participants’ blood pressure and heart rate were measured following the
guidelines provided by the Seventh Joint National Committee (JNC 7, 2003) on the
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The principal
investigator used the auscultatory method of blood pressure measurement with a random
zero sphygmomanometer to obtain blood pressure. Participants were required to sit
comfortably for five minutes with the back and arm supported, the legs uncrossed, and
the upper arm at the level of the right atrium before the first reading was taken. Two
readings were taken five minutes apart with cuff on the right arm and the study
participant seated. An appropriate-sized cuff with the cuff bladder able to encircle at least
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80% of the arm was used to ensure accuracy of the results. Two blood pressure
measurements were averaged and the average blood pressure was classified using the
protocol. Systolic blood pressure 120 to 139 mmHg or diastolic blood pressure of 80 to
89 mmHg was classified as prehypertension. Participants’ with a systolic blood pressure
of 140 to 159 mmHg or a diastolic blood pressure of 90 to 99 mmHg were described as
Stage 1 hypertension. Similarly, participants with systolic blood pressure of greater or
equal to 160 mmHg or diastolic blood pressure of greater or equal to 100 mmHg were
classified as Stage 2 hypertension. Systolic blood pressure that is less than 120 mmHg or
diastolic blood pressure less than 80 mmHg was described as normal blood pressure.
Anthropometric Assessment
Height, weight, waist, and hip measurements were obtained from each participant
by the same investigator. Subjects were required to remove shoes and heavy outer
garments before the measurements of height and weight. Height was obtained using a
scale-mounted measuring tool and measured to the nearest centimeter. A calibrated
balance scale or an electronic scale was used to assess subject’s weight to the nearest
tenth of a kilogram. Although different weight scales were used at each of the different
locations, they were standardized to no more than a 0.05 pound difference by weighing
the principal investigator on each of the scales. The subjects’ height and weight were
measured following the World Health Organization’s MONICA [Monitoring Trends and
determinants in Cardiovascular disease] project guidelines (Molarius, Seidell, Sans,
Tuomilehto, & Kuulasmaa, 2000). Body mass index (BMI) was calculated using each
individual weight in kilograms divided by their height in meters squared (WHO, 2000).
Waist and hip circumference were measured to further characterize the sample. The same
tape measure was used for all the subjects to measure the waist and hip. The waist was
measured midway between the bottom of the ribs and the top of the hip bone and hips at
the widest point between the hips and buttocks in the standing position and the waist-hipratio (WHR) was calculated in centimeters. WHR was computed as waist divided by hip
(WHO, 2000). Similarly, WC was measured around the bare abdomen using the same
measuring tape at the nearest 0.1 cm at the high point of the iliac crest at minimal
respiration (CDC, 2005). The NCEP ATP III criteria for defining abdominal obesity as a
WC > 35 inches (88 cm) in women and > 40 inches (102 cm) in men (Expert Panel on
Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001) was
used as well as the WHO parameter for abdominal obesity which is WHR of > 0.80 in
women or > 0.90 in men (Medscape, Connect, Care, Surgery, & Today, 2005; Pouliot et
al., 1994).
Blood Collection for Traditional and Emerging Risk Factors
After a 10-hour overnight fast, blood samples for glucose, insulin, hs-CRP,
fibrinogen, PAI-1, sICAM-1, E-selectin, total cholesterol, LDL-cholesterol, HDLcholesterol, and triglycerides, were obtained. The procedure for blood sample collection
was discussed with each participant. There was no associated cost regarding the blood
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collection to the participant. The principal investigator carried all needed supplies to each
of the recruitment sites: the Center for Health Evaluation and Lifestyle Promotion at the
University of Tennessee Health Science Center, Internal Medicine and Family Practice
clinics as well as collected the blood samples. Possible risk of bruising at the
venipuncture site was shared with participants.
About 30 cc of blood was collected from each participant into BD vacutainer SST
tube for serum determinations in chemistry and lavender tubes containing EDTA for
anticoagulation. Each tube was inverted after collection to prevent clotting. Samples were
stored in ice for not more than 2 hours until they were centrifuged. The plasma and serum
was separated into cryo tubes and stored at -80 °C until processing. Instructions regarding
proper handling of serum/plasma samples as well as overnight mailing and shipping
procedures were adhered to. Sample analyses were conducted at the University of Miami
and the University of Tennessee Health Science Center using the procedures described in
the following sections.
Traditional Cardiovascular Risk Factors
Glucose
Plasma glucose was measured in triplicate using the glucose oxidase method
(Kadish & Hall, 1965). The American Diabetes Association (2007) diagnostic criteria
were used to identify impairment in glucose metabolism. Fasting plasma glucose levels
of 100-125 mg/dl were classified as impaired fasting glucose (IFG), while levels ≥ 126
mg/dl were classified as diabetes mellitus.
Lipid Analyses
The chemistry assays were performed by the University of Miami Diabetes
Research Institute on the automated analyzer (Roche Cobas-Mira) utilizing the
manufacturer’s commercially available kits. Instrument set-up, run procedures, and
maintenance policies were strictly adhered to according to the manufacturer’s
instructions. The description of the laboratory procedures was provided by Dr. Armando
Mendez, co-director of the laboratory (personal communication, August 22, 2008).
Normal values for total cholesterol (< 200 mg/dl), LDL-cholesterol (< 130 mg/dl), HDLcholesterol (≥ 50 mg/dl), and triglyceride levels (< 150 mg/dl) are based upon the
National Cholesterol Education Program criteria (Cleeman & Lenfant, 1998; Executive
Summary of The Third Report of The National Cholesterol Education Program (NCEP)
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in
Adults [Adult Treatment Panel III], 2001).
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Total Cholesterol
Plasma cholesterol was measured after release from its esters by an ester
hydrolase. The free cholesterol was then oxidized by cholesterol oxidase, producing
hydrogen peroxide. The hydrogen peroxide, when combined with 4-aminoantipyrine and
phenol, forms a chromophore in an amount which is directly proportional to the
cholesterol concentration in the sample and is quantitated photometrically at 540 nm
(Allain, Poon, Chan, Richmond, & Fu, 1974). Intra-assay and inter-assay CVs are 2.5 and
3.5%, respectively (A. Mendez, personal communication, August 22, 2008).
HDL-Cholesterol
Dextran sulfate (50,000 MW) and magnesium precipitate low density lipoproteins
(LDL) and very low density lipoproteins (VLDL) in plasma or serum. After
centrifugation, the HDL remains in the supernatant. The inter-assay CV is 2.5% (A.
Mendez, personal communication, August 22, 2008).
LDL-Cholesterol
LDL-cholesterol was calculated using the Friedewald formula (Friedewald, Levy,
& Fredrickson, 1972), which states that LDL-cholesterol = total cholesterol - (fasting
triglyceride/5) - (HDL-cholesterol). This method has been shown to correlate well with
ultracentrifugally derived LDL-cholesterol values up to triglyceride values of 400 mg/dl.
Triglyceride
Plasma triglyceride level was measured after hydrolysis by lipoprotein lipase to
glycerol and fatty acids. Glycerol was enzymatically phosphorylated and then oxidized to
release hydrogen peroxide that peroxidized to form a quinoneimine chromophore which
can be read at 490 nm in the spectrophotometer. The inter-assay CV is 5.3%. (A.
Mendez, personal communication, August 22, 2008).
Emerging Cardiovascular Risk Factors Screening
These tests were performed on the Dade-Behring nephelometer using the
manufacturer’s reagents, quality controls, and methods. The nephelometer measures the
light scatter due to the formation of immune complexes between standards or unknowns
and specific antibodies. The extent of light scatter was directly proportional to the antigen
concentration. All tests utilize a serum standard that was diluted to generate a standard
curve and to minimize matrix effects in this matrix-sensitive methodology. Instrument
set-up, run procedures, and maintenance policies were strictly adhered to according to the
manufacturer’s instructions. Reagents used in the nephelometer were obtained from
Dade-Behring.
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Fibrinogen
Diluted EDTA plasma was incubated with rabbit anti-human fibrinogen antibody
to form immune complexes. The serum standard has a reference value in the range 2.0 2.5 g/l. The normal range is from 1.8 - 3.5 g/l and the intra-assay and inter-assay CVs are
2.7% and 2.6%, respectively (Ernst, 1993). Normal laboratory values are estimated at
200 - 350 mg/dl (A. Mendez, personal communication, August 22, 2008).
High Sensitivity C-reactive Protein (hs-CRP)
Diluted serum or EDTA plasma is incubated with polystyrene particles coated
with monoclonal antibodies to CRP to produce agglutination and light scattering in
proportion to the concentration of antigen. The serum standard was diluted to produce a
standard curve from 0.08 to 6 mg/l, and healthy individuals are expected to have values
of < 3 mg/l. Mean values for men with and without myocardial infarction were 1.51 and
1.13 mg/l, respectively (Rifai, Tracy, & Ridker, 1999). Intra-assay and inter-assay CVs
are < 4.4% and < 5.7%, respectively. Hs-CRP values range between 0.3 and 8.6 mg/L in
healthy men and between 0.2 and 9.1 mg/L in healthy women (Ridker, 2008). The
following interpretation of hs-CRP results has been recommended by the Center for
Disease Control and Prevention (CDC) and the American Heart Association (AHA) for
cardiovascular disease risk classification: < 1mg/L = low risk, 1- 3mg/L = average risk
and > 3mg/L = high risk (A. Mendez, personal communication, August 22, 2008).
Plasminogen Activator Inhibitor-1 (PAI-1), E-selectin, and Soluble ICAM-1
The simultaneous quantification of the following analytes—Plasminogen
Activator Inhibitor-1 (PAI-1, total), E-selectin, and sICAM-1—were performed using the
multiplex assay kit manufactured by Millipore Corporation (St. Charles, MO). Prior to
beginning the assay, a diagram placement of background, standards, controls, and serum
samples on Well Map Worksheet was set-up in a vertical configuration and the assay was
run in duplicate. Consistent with manufacturer’s guidelines, appropriate matrix solution
was added to the Background, Standards, and Control wells. Assay buffer was used as
matrix solution before adding the samples into the appropriate wells. Mixed beads were
subsequently added, sealed, and covered with aluminum foil and placed overnight on a
plate shaker. Vacuum filtration was used to remove the wash buffer before adding
Streptavidin-Phycoerythrin, which was placed in a plate shaker for 30 minutes. Vacuum
filtration was also done afterwards to wash buffer twice before the plate was finally run
on a Luminex instrument. The following values are used in clinical research for healthy
controls: Soluble ICAM-1 range is 98.8–320 ng/ml, E-selectin range is 17.9–79.2 ng/ml,
while PAI-1 is 21.0 +/- 7.2 ng/ml (LINCO Research, 2005).
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Insulin
Serum fasting insulin was measured in serum samples using a solid phase 125I
radioimmunoassay (Coat-A-Count, Diagnostic Products Corp.) at the University of
Miami Diabetes Research Institute. The assay utilizes a tube-immobilized anti-human
insulin antibody that provides a convenient overnight (or, alternatively, a 3-hour)
incubation after addition of cold antigen and 1251-insulin label in buffer, followed by
simple decanting of the supernatant, and gamma counting. The assay is sensitive down to
1.2µU/ml. At mid-curve there is 40% cross-reactivity for proinsulin. Intra-assay and
interassay CVs are 3.1 - 9.3% and 4.9 - 10.0%, depending on antigen concentration (A.
Mendez, personal communication, August 22, 2008). Quantitative insulin sensitivity
check index [QUICKI] (Katz et al. 2000) was derived using the formula 1/log insulin +
log glycemia in mg/dl. QUICKI values < 0.3 indicate insulin resistance (VelasquezMieyer, Cowan, Neira, & Tylavsky, 2008).
Data Collection Procedure
Permission to conduct this study was obtained from the University of Tennessee
Institutional Review Board (IRB); see Appendix C. Recruitment was conducted through
IRB-approved flyers (Appendix D) and contact with area nurse practitioners as well as
Family Practice and Internal Medicine clinic owners across two southern states. Verbal
approval of the Director of Health Works was obtained to recruit participants from that
facility for the study.
Site Preparation
IRB-approved recruitment posters and fliers were placed in visible areas within
the college community and area family/internal medicine clinics about three weeks prior
to the actual date for data collection. The contact telephone number of the principal
investigator was included on the fliers to answer questions and schedule participants for
data collection. Volunteer participants were screened for eligibility to participate in the
study, and instructions on the study protocol were provided. The information packet was
given to participants in addition to IRB-approved Consent Form (Appendix E),
demographic questionnaire, 7-Day PAR Questionnaire and anthropometric assessments.
Participants were required to have an overnight fast of 10-12 hours prior to blood
collection for analysis. A heart healthy diet was provided for participants following
completion of the study protocol.
Selection of Participants
Individuals who were interested in the study indicated their willingness and the
principal investigator provided them with an overview of the study aims, procedures,
risks, and benefits. A date for testing was set for eligible individuals and instructions
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were given to fast for 10 hours prior to the testing session. On the day of testing, the
study protocol was explained, questions were answered, and a written informed consent
was obtained from qualified participants.
Data Collection
Study criteria checklist was presented to all participants to establish eligibility for
the study. Verbal permission to perform urine pregnancy test was received. Participants
were instructed to provide voided specimen for testing. Height and weight were measured
to calculate BMI. Eligible participants continued with the remaining requirements for the
study. The remaining testing procedures were initiated in the following sequence: resting
blood pressure; completion of demographic and 7-Day PAR Questionnaires; waist, hip
measures, and finally blood collection. About 30 cc of venous blood was collected by the
investigators. The questionnaires contained no personal identifying information; only
codes were used for purposes of data analysis.
The completed questionnaires were reviewed by the principal investigator at the
time of collection. Study questionnaires with missing data were returned to the
participant to review and complete. The principal investigator provided assistance to
participants with missing data, if needed.
Participants who completed all study protocol received a $20.00 cash gift as an
appreciation for their participation. Study participants signed a form acknowledging
receipt of the cash gift. The form was co-signed by the investigators and stored in a
secure location.
Data Transfer
The data collected from the questionnaires, anthropometric measures, and
laboratory results were recorded in a password-protected Microsoft Excel computer
spreadsheet. All data were coded to protect participants’ confidentiality and promote
anonymity. Laboratory results were shared with participants as they became available,
along with a recommendation to review study results with their primary care providers.
Data Analysis
Data analysis was conducted using SAS version 9.1.3 (Cary, NC). Statistical
analysis for this study included descriptive statistics. The study sample was characterized
using measures of central tendency (means and median), variability (range and standard
deviation), and frequency distributions (symmetrical and asymmetrical). Descriptive data
consisting of age, income level, tobacco use, illicit drug use, BMI, WHR, WC, blood
pressure, physical activity levels, blood glucose, insulin, QUICKI, lipid profile, hs-CRP,
fibrinogen, PAI-1, sICAM-1, and E-selectin levels were used to summarize the
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demographic data and cardiovascular risk factors for the entire sample based on the total
sample and by their weight categories. The relationships and degree of association among
the variables were examined using Spearman’s Rho correlation coefficients. Differences
in risk factors between the obese and normal weight groups were explored using the
Mann Whitney Wilcoxon test for continuous variables and chi-square for nominal
variables. For inferential statistics, an alpha level of 0.05 was set a priori for statistical
significance.
Specific Aim One
Describe the prevalence of traditional and emerging cardiovascular risk factors in
African American women, ages 18 to 45, without a known history of cardiovascular
disease.
The prevalence of traditional and emerging cardiovascular risk factors was
determined by the proportion of the sample that had the risk factor divided by the total
number of individuals in the sample. Descriptive statistics were used to derive
information regarding the data distribution, mean, median, range, standard deviation, and
frequency distributions of the study sample.
Specific Aim Two
Examine the relationship between BMI, physical activity levels, and other
traditional (diabetes, dyslipidemia, tobacco use, family history of CVD, hypertension)
and emerging (QUICKI, hs-CRP, PAI-1, fibrinogen, E-selectin, sICAM-1)
cardiovascular disease risk factors in African American women.
Correlation analyses were computed to determine the interrelationship among the
study variables (age, BMI, physical activity levels [kcal/week, hours of moderate weekly
activity, days/week of moderate activity], weight, height, waist circumference, waist-hipratio, and traditional and emerging cardiovascular risk factors). Spearman Rho
correlation coefficient (r) was used to approximate the magnitude and direction of
relationships among the variables. Graphic plots were performed to facilitate the
visualization of the relationship between the variables of interest and to determine their
linearity.
Specific Aim Three
Compare traditional and emerging risk factors among normal weight and obese
African American women.
Since non-parametric statistics are most appropriately used when the sample sizes
are small, the Mann Whitney U test was used to examine the differences in
cardiovascular risk factors between the normal weight and obese groups. For traditional
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risk factors and some emerging risk factors, normative values were used to determine
whether an individual was classified as having the risk factor. The chi-square test
provided an assessment of differences in the frequency of the risk factors between the
normal weight and obese groups.
Consideration of Human Subjects
The study received approval from the University of Tennessee Health Science
Center Institutional Review Board. Appropriate guidelines were maintained to ensure
anonymity and confidentiality of subject participants. A unique identification code was
assigned to each subject to facilitate data analysis and data collection forms were stored
in a secure separate location. Blood samples were collected and stored in tubes labeled
with the unique identification code in a -80 °C freezer for batch analysis. Samples were
sent to the laboratory without personal identification and data were reported on an Excel
spreadsheet using the identification codes.
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CHAPTER 4. RESULTS
Introduction
The purpose of this study was to examine the impact of body weight on the
traditional and emerging risk factors for cardiovascular disease in young African
American women who have no history of cardiovascular disease. A general description
of the sample population and their cardiovascular risks is provided in the following
paragraphs. Additionally, the relationship between cardiovascular risk factors was
explored. The results and statistical analyses of each research question are presented in
this chapter.
Description of the Sample
The study sample consisted of 48 African American women from the mid-south.
The mean age of the women was 31.58 (range 18-45 years). The sample description is
provided in Table 4.1 for the whole group. The majority of the women (62.5%) were
unmarried, with about 35.4% having completed or almost completed high school/GED,
while 64.6% had some form of college education. Similarly, 62.5% of the women were
employed, while 37.5% were unemployed. Three-fourths (75%) of the women reported
an annual household income < $50,000, while 14.58% of the participants had an annual
household income > $100,000. Five (10.42%) of the women in our study admitted to the
use of marijuana, while the remainder of the participants denied any use of illicit drugs.
The vast majority of our participants denied any preexisting medical condition; only 2
(4.17%) of the women reported a medical history of hypertension and diabetes.
Research Findings
Study findings are reported for each specific aim and question in sequence, with
each aim restated, followed by the results of the statistical analyses.
Primary Aim One
Describe the prevalence of traditional and emerging cardiovascular risk factors in
African American women, ages 18 to 45, without a known history of cardiovascular
disease.
The prevalence of traditional and emerging cardiovascular disease risk factors
was determined by the proportion of the sample that had the risk factor divided by the
total number of individuals in the sample. Traditional risk factors of physical inactivity,
tobacco use, and family history of CVD were assessed by self-report using the 7-Day
PAR Questionnaire. The most common traditional risk factor identified was physical
inactivity. A vast majority of our study population (n = 35, 72.92%) did not meet
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Table 4.1 Subjects’ Demographic Characteristics
______________________________________________________
Variable

Total Sample
n (%)
______________________________________________________
Marital Status
Married
Divorced
Never married
Separated
Other

13 (27.08%)
1 (2.08%)
30 (62.5%)
3 (6.25%)
1 (2.08%)

Education Level
Some high school
High school/GED
2-year college
4-year college
Graduate school

3 (6.25%)
14 (29.17%)
15 (31.25%)
8 (16.67%)
8 (16.67%)

Employment Status
Unemployed
Student
Part-time
Full time
Home maker

14 (29.17%)
2 (4.17%)
3 (6.25%)
27 (56.25%)
2 (4.17%)

Household Income
< $25,000
< $50,000
< $75,000
> $100,000

20 (41.67%)
16 (33.33%)
5 (10.42%)
7 (14.58%)

Illicit Drug Use
Marijuana

5 (10.42%)

Past Medical History
Hypertension
2 (4.17%)
Diabetes
2 (4.17%)
_____________________________________________________
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recommended guidelines of at least 30 minutes of moderate intensity physical activity on
5 or more days of the week (CDC, 1999). Twenty-eight (58.3%) women reported a
positive family history of CVD. Positive family history of CVD was defined as a history
of myocardial infarction, coronary artery disease, congestive heart failure or
cerebrovascular accident in a first-degree relative or grandparent (Bertuzzi, Negri,
Tavani, & La Vecchia, 2003). Another traditional CVD risk factor that was prevalent in
our study population was obesity (n = 27, 56.25%). Twelve (25%) of the women reported
current tobacco use; however, the amount of tobacco use was not elicited. For the other
traditional risk factors, normative values were used to determine whether an individual
was classified as having the risk factor. The prevalence of traditional risk factors is
summarized in Table 4.2.
Study participants were screened for emerging CVD risk factors (Table 4.3). Our
results showed that all the women (N = 48) had a QUICKI score of < 0.3, which is
suggestive of insulin resistance (Velasquez-Mieyer, Cowan, Neira, & Tylavsky, 2008).
Twenty-two (45.8%) of the participants had both elevated high sensitivity C-reactive
protein (hs-CRP > 2 mg/dl) and Plasminogen Activator Inhibitor-1 (PAI-1 > 28.2 ng/ml)
levels. Fifty-six percent (n = 27) of the participants had an abnormal fibrinogen (>350
mg/dl) level. Three participants (6.15%) had an elevated E-selectin level (> 79.2 ng/ml),
while 4.17% (n = 2) had elevated sICAM level (> 320 ng/ml). Normative values have not
yet been determined for PAI-1, E-selectin, sICAM, and QUICKI. Cutpoints used to
classify individuals as having the risk factor were based on research studies.
Descriptive statistics were used to derive information regarding the data
distribution of the study sample. This statistical procedure provided information
regarding the characteristics of the study population such as measures of central tendency
(mean, median) and variability (standard deviation, range). Table 4.4 shows a summary
of the descriptive statistics for the traditional and emerging cardiovascular risk factors for
the entire sample.
Primary Aim Two
Examine the relationship between BMI, physical activity levels, and other
traditional and emerging cardiovascular disease risk factors in African American women.
Correlation analyses were computed to determine the interrelationship among the
study variables (BMI, physical activity levels [kilo calorie per week, hours of moderate
weekly physical activity, days per week of moderate physical activity], and traditional
[systolic and diastolic blood pressure, fasting blood glucose, total cholesterol, high
density lipoprotein cholesterol (HDL-c), low density lipoprotein cholesterol (LDL-c),
triglycerides] and emerging cardiovascular risk factors [high sensitivity C-reactive
protein (hs-CRP), fibrinogen, E-selectin, soluble Intercellular Adhesion Molecule-1
(sICAM-1), QUICKI, and Plasminogen Activator Inhibitor-1, (PAI-1)]. Spearman Rho
correlation coefficient (r) was used to approximate the magnitude and direction of
relationships among the continuous variables while Kendall Tau’s were used to examine
the relationships among dichotomous variables and continuous variables. Graphic plots
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Table 4.2 Prevalence of Traditional Cardiovascular Disease Risk Factors (N = 48)
_________________________________________________________
Cardiovascular Disease Risk Factors

Prevalence Rates
n (%)
_________________________________________________________
Diabetes

2 (4.17%)

Family history of CVD

28 (58.3%)

Tobacco use

12 (25%)

Hypertension

2 (4.17%)

Elevated total cholesterol

9 (18.75%)

High density lipoprotein cholesterol (HDL-c)

18 (37.5%)

Low density lipoprotein cholesterol (LDL-c)

8 (16.7%)

Elevated triglycerides

3 (6.25%)

Physical inactivity (< 5days of physical activity/week) 35 (72.92%)
Obesity
27 (56.25 %)
_________________________________________________________
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Table 4.3 Prevalence Rates of Emerging Cardiovascular Disease Risk Factors (N = 48)
__________________________________________________________
Cardiovascular Disease Risk Factors

Rates
n (%)
__________________________________________________________
High sensitivity C-reactive protein (hs-CRP)

22 (45.8%)

Fibrinogen*

27 (56.25%)

Quantitative Insulin Sensitivity Check Index
(QUICKI)*

48 (100%)

Plasminogen Activator Inhibitor-1 (PAI-1)**

22 (45.8%)

E-selectin**

3 (6.15%)

Soluble Intercellular Adhesion Molecule-1
2 (7.41%)
(sICAM-1)*
__________________________________________________________
* N = 47 due to technical difficulties. ** Indicates that the norms for these
emerging risk factors are not yet established. Values used are from
reported research data.
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Table 4.4 Descriptive Statistics of Traditional and Emerging Cardiovascular Risk
Factors
_______________________________________________________________
CVD Risk
Median
Mean
Std Dev
Range
Factors
(±SD)
Min, Max
_______________________________________________________________
Average
114.50
114.96
13.69
90.00, 158.00
systolic blood
pressure
(mmHg)
Average
diastolic blood
pressure
(mmHg)

72.00

72.82

9.25

56.50, 97.00

KCAL/week

258.35

277.32

58.45

215.60, 504.35

Hours of moderate physical
activity/week

13.15

21.11

20.71

0.00, 73.00

Days per week
3.00
of moderate
physical activity

3.21

2.18

0.00, 7.00

Glucose
(mg/dl)

87.00

95.52

54.51

54.00, 439.00

Total cholesterol (mg/dl)

176.50

177.15

28.68

108.00, 243.00

HDL-c(mg/dl)

52.00

52.85

13.92

27.00, 100.00

LDL-c(mg/dl)

111.50

108.02

24.29

51.00, 160.00

Triglycerides
(mg/dl)

62.00

84.02

74.53

38.00, 532.00

QUICKI

0.26

0.26

0.01

0.19, 0.29

Hs-CRP
(mg/L)

1.85

6.66

14.34

0.10, 80.80
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Table 4.4 (continued)
__________________________________________________________________
CVD Risk
Median
Mean
Std Dev
Range
Factors
(±SD)
Min, Max
__________________________________________________________________
Fibrinogen
(mg/dl)

387.69

381.74

135.94

14.28, 700.49

E-selectin
(ng/ml)

23.03

27.46

23.36

4.00, 115.24

sICAM-1
(ng/ml)

80.31

105.02

96.06

2.91, 515.95

PAI-1
23.79
32.69
27.57
0.37, 104.17
(ng/ml)
__________________________________________________________________
Kcal/week = kilocalorie per week, HDL-c = high density lipoprotein cholesterol,
LDL-c = low density lipoprotein cholesterol, QUICKI = quantitative insulinsensitivity check index, hs-CRP = high sensitivity C-reactive protein.
were performed to facilitate the visualization of the relationship between the variables of
interest and to determine their linearity. Table 4.5 provides a summary of the
correlational analyses performed among these variables.
Our results showed a significant positive relationship between BMI and systolic
blood pressure (r = 0.67; p < 0.0001). This finding suggest that the higher the BMI, the
higher the systolic blood pressure. The correlation between kilocalories of energy
expended per week and systolic blood pressure (r = -0.03; p = 0.85) and between hours
spent in moderate physical activity per week and systolic blood pressure was (r = -0.11; p
= 0.45). The association between the number of days spent in moderate physical activity
and systolic blood pressure was (r = 0.3; p = 0.84). These were not statistically significant
between the groups.
A significant relationship was noted between BMI and diastolic blood pressure (r
= 0.61; p < 0.0001). Just like for systolic blood pressure, the higher the BMI, the higher
the diastolic blood pressure. There was a non significant association between kilocalories
expended per week and diastolic blood pressure was (r = -0.18; p = 0.21) and between
hours spent in moderate physical activity per week and diastolic blood pressure (r =
-0.09; p = 0.54). The association between the number of days participants spent in
moderate physical activity and diastolic blood pressure (r = -0.24; p = 0.09) was also not
significant.
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Table 4.5 Relationship among BMI, Physical Activity, and CVD Risk Factors (N = 48)
_____________________________________________________________________
CVD
Hours of
Days of at Least
Risk
BMI
kcal/wk
Moderate
Moderate
Factors
Activity Wkly Activity Wkly
_____________________________________________________________________
Systolic
blood
pressure

r = 0.67
p < .0001

r = -0.03
p = 0.85

r = -0.11
p = 0.45

r = 0.03
p = 0.84

Diastolic
blood
pressure

r = 0.61
p < .0001

r = -0.18
p = 0.21

r = -0.09
p = 0.54

r = -0.24
p = 0.09

Fasting
blood
glucose

r = 0.12
p = 0.41

r = -0.22
p = 0.12

r = -0.20
p = 0.18

r = 0.17
p = 0.23

QUICKI*

r = -0.12
p = 0.41

r = 0.22
p = 0.12

r = 0.20
p = 0.18

r = -0.17
p = 0.23

Total
cholesterol

r = -0.06
p = 0.66

r = 0.21
p = 0.14

r = 0.17
p = 0.25

r = -0.07
p = 0.65

High density
Lipoprotein
cholesterol

r = -0.35
p = 0.01

r = 0.24
p = 0.11

r = 0.22
p = 0.13

r = -0.16
p = 0.30

Low density
lipoprotein
cholesterol

r = -0.04
p = 0.76

r = 0.28
p = 0.05

r = 0.27
p = 0.07

r = 0.12
p = 0.43

Triglycerides

r = 0.30
p = 0.04

r = -0.30
p = 0.04

r = -0.43
p = 0.002

r = 0.12
p = 0.41

High
sensitivity
CRP

r = 0.51
p = 0.0002

r = -0.12
p = 0.41

r = -0.22
p = 0.14

r = 0.12
p = 0.41

Fibrinogen

r = 0.49
p = 0.0004

r = 0.01
p = 0.93

r = -0.15
p = 0.32

r = 0.06
p = 0.67
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Table 4.5 (continued)
_____________________________________________________________________
CVD
Hours of
Days of at Least
Risk
BMI
kcal/wk
Moderate
Moderate
Factors
Activity Wkly Activity Wkly
_____________________________________________________________________
E-selectin

r = 0.21
p = 0.15

r = -0.24
p = 0.10

r = -0.23
p = 0.12

r = 0.22
p = 0.13

sICAM-1

r = 0.33
p = 0.02

r = -0.27
p = 0.06

r = -0.25
p = 0.09

r = 0.31
p = 0.03

PAI-1

r = 0.21
P = 0.15

r = -0.18
p = 0.23

r = -0.19
p = 0.21

r = 0.13
p = 0.36

Tobacco use

r = 0.05
p = 0.65

r = -0.15
p = 0.22

r = -0.01
p = 0.96

r = -0.25
p = 0.05

Family hx
of CVD

r = -0.01
p = 0.93

r = -0.08
p = 0.52

r = 0.02
p = 0.84

r = -0.02
p = 0.87

HTN

r = 0.21
p = 0.08

r = 0.09
p = 0.41

r = -0.05
p = 0.67

r = 0.18
p = 0.16

*N = 47 due to technical difficulties. QUICKI = quantitative insulin-sensitivity check
index, sICAM-1 = soluble intercellular adhesion molecule-1, PAI-1 = plasminogen
activator inhibitor-1, Family hx of CVD = family history of cardiovascular disease,
HTN = hypertension.
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The results of our analyses showed a negative significant association between
BMI and HDL-cholesterol (r = -0.35; p = 0.01). This means that the higher the BMI, the
lower the HDL-cholesterol levels. A non significant association was noted between
kilocalories expended per week and HDL-cholesterol (r = 0.24; p = 0.11) and also
between the hours spent in moderate physical activity and HDL-cholesterol (r = 0.22; p =
0.13). A non- significant association was noted between the number of days spent in
moderate physical activity and HDL-cholesterol (r = -0.16; p = 0.30).
Our findings showed a non significant association between BMI and LDLcholesterol (r = -0.04; p = 0.76). There was a significant association between the
kilocalories of energy expended per week and LDL-cholesterol (r = 0.28; p = 0.05). This
finding is surprising as it tends to suggest that the participants who exerted more
kilocalories of energy per week had higher LDL-cholesterol. A non significant
association was observed between hours of moderate physical activity per week and
LDL-cholesterol (r = 0.27; p = 0.07) as well as between days spent in moderate physical
activity and LDL-cholesterol (r = 0.12; p = 0.43).
We also observed a significant correlation between BMI and hs-CRP (r = 0.51;
p = 0.0002). This finding suggests that a higher BMI was positively associated with a
higher hs-CRP level. There was a non significant association between kilocalories of
energy expended per week and hs-CRP (r = -0.12; p = 0.41) as well as between hours
spent in moderate physical activity per week and hs-CRP (r = -0.22; p = 0.14). The
association between days spent in moderate physical activity per week and hs-CRP was
non significant (r = 0.12; p = 0.41).
The results of our analyses showed a significant association between BMI and
fibrinogen (r = 0.50; p = 0.0004). Again, this indicates that a higher BMI was associated
with a higher fibrinogen level. A non significant association was noted between
kilocalories of energy expended per week and fibrinogen (r = 0.01; p = 0.92) and between
hours spent in moderate physical activity per week and fibrinogen (r = -0.15; p = 0.32) as
well as a non significant association between days spent in moderate physical activity per
week and fibrinogen (r = 0.06; p = 0.67).
Our findings also showed a significant association between BMI and sICAM-1
(r = 0.33; p = 0.02). Again, this implies that the higher the BMI, the higher the sICAM-1
level. We determined there was a non significant association between the kilocalorie
expended based on body weight and sICAM-1 (r = -0.27; p = 0.06) as well as between
the number of hours of moderate physical activity performed weekly by individual
participants and sICAM-1 level (r = -0.25; p = 0.09). There was a significant association
between the number of days participants spent in moderate physical activity per week and
sICAM-1 level (r = 0.31; p = 0.03).
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Primary Aim Three
Compare traditional and emerging cardiovascular risk factors among normal
weight and obese African American women.
The demographic characteristics of the normal weight and obese groups are
shown in Table 4.6. Our data revealed that more women 66.67% (n = 18) in the obesity
group were single compared to 57.14% (n = 12) of the normal weight group. Forty-one
percent (n = 11) of the obese group had a high school degree/GED or less compared to
28.6% (n = 6) of the normal weight group. The study participants had comparable levels
of college education (59.26%, n = 16 for normal weight group vs. 71.4%, n = 15 for
obese group, p = NS). About 30% (n = 8) of the obese group described themselves as
unemployed compared to 28.6% (n = 6) of the normal weight group. Seventeen (63%) of
the obese group were employed compared to 61.9% (n = 13) of the normal weight group.
With regards to annual household income, 85.2% (n = 23) of the obese group in our study
reported an annual income that was < $50,000, while 61.9% (n = 13) of the normal
weight group reported similar income levels. Almost twice as many participants in our
normal weight group (38.1%, n = 8) reported an annual household income of $50,000 to
$100,000, compared to 14.8% (n = 4) of the obese group. Three (11.11%) participants in
our obese group admitted to the use of marijuana compared to 9.52% (n = 2). Two of our
obese participants reported a past medical history of hypertension and diabetes (n = 2,
7.41%). Details of descriptive statistics for the normal weight and obese groups are
further summarized in Table 4.7.
Since non-parametric statistics are most appropriately used when the sample sizes
are small, the Mann Whitney U test was used to examine the differences in
cardiovascular risk factors between the normal weight and obese groups. Continuous
variables measured in this analysis were systolic and diastolic blood pressure, lipid
profile (total cholesterol, HDL-c, LDL-c, triglycerides), fasting plasma glucose, hours
spent weekly on moderate physical activity, number of days of the week spent in
moderate physical activity, QUICKI, hs-CRP, fibrinogen, E-selectin, sICAM-1, and PAI1. Values are summarized in Table 4.8.
A summary of the results of the independent sample t-test statistics procedures
shown in Table 4.8 indicated that the obese weight group had higher systolic (p =
0.0002) and diastolic blood pressure (p = 0.0007), and lower HDL-cholesterol (p = 0.01)
and higher triglyceride levels (p = 0.02) than the normal weight group. There were no
statistically significant difference between groups in the levels of total cholesterol (p =
0.6065), LDL-cholesterol (p = 0.8040), hours of moderate physical activity performed
weekly (p = 0.3597), and the number of days per week of moderate physical activity (p =
0.6670). A similar trend was found with the emerging cardiovascular risk factors between
the two groups. The obese group had significantly higher levels of hs-CRP (p = 0.0020),
and fibrinogen (p = 0.0109) compared to the normal weight group. However, the
difference in the levels of QUICKI (p = 0.3382), E-selectin (p = 0.2884), sICAM (p =
0.0950), and PAI-1 (p = 0.3985) between the two groups was not statistically significant.
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Table 4.6 Demographic Characteristics by Weight Groups
__________________________________________________________________
Normal Weight Group
Obese Group
(n = 21)
(n = 27)
n (%)
n (%)
__________________________________________________________________
Variable

Marital Status
Married
Divorced
Never Married
Separated
Other

7 (33.33%)
0
12 (57.14%)
2 (9.52%)
0

6 (22.22%)
1 (3.70%)
18 (66.67%)
1 (3.70%)
1 (3.70%)

Education Level
Some high school
High school/GED
2-year college
4-year college
Graduate School

1 (4.76%)
5 (23.81%)
5 (23.81%)
5 (23.81%)
5 (23.81%)

2 (7.41%)
9 (33.33%)
10 (37.04%)
3 (11.11%)
3 (11.11%)

Employment Status
Unemployed
Student
Part-time
Full time
Home maker

6 (28.57%)
1 (4.76%)
1 (4.76%)
12 (57.14%)
1 (4.76%)

8 (29.63)
1 (3.70%)
2 (7.41%)
15 (55.56%)
1 (3.70%)

Household Income
< $25,000
> $25,000-$50,000
> $50,000-$75,000
> $75,000-$100,000

8 (38.10%)
5 (23.81%)
3 (14.29%)
5 (23.81%)

12 (44.44%)
11 (40.74%)
2 (7.41%)
2 (7.41%)

Illicit Drug Use
Marijuana

2 (9.52%)

3 (11.11%)

Past Medical History
Hypertension
0
2 (7.41%)
Diabetes
0
2 (7.41%)
__________________________________________________________________
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Table 4.7 Comparison of Means of the Traditional and Emerging Cardiovascular Risk
Factors among Normal Weight and Obese African American Women
________________________________________________________________________
Risk Factors

Normal Weight
Obese Group
(n = 21)
(n = 27)
M (±SD)
M (±SD)
________________________________________________________________________
ASBP mmHg

106.12 (9.98)

121.83 (12.25)

ADBP mmHg

67.36 (6.61)

77.07 (8.84)

TC mg/dl

178.19 (25.04)

176.33 (31.67)

HDL-c mg/dl

57.86 (11.34)

48.96 (14.67)

LDL-c mg/dl

108.19 (23.84)

107.89 (25.08)

Trig mg/dl

66.76 (33.98)

97.44 (93.41)

Glucose mg/dl

85.33 (10.07)

103.44 (71.72)

Hrs of moderate wkly activity

24.02 (22.07)

18.86 (19.71)

Days/wk of moderate activity

3.43 (2.60)

3.04 (1.83)

QUICKI

0.26 (0.01)

0.26 (0.02)

Hs-CRP mg/l

1.88 (2.84)

10.38 (18.25)

Fibrinogen mg/dl

327.68 (126.12)

425.41 (129.77)

E-selectin ng/ml

25.01 (25.20)

29.37 (22.13)

sICAM -1 ng/ml

77.86 (42.98)

126.15 (119.17)

PAI-1 ng/ml
27.96 (22.99)
36.37 (30.59)
M (±SD) = Mean (Standard deviation), ASBP = average systolic blood pressure, ADBP =
average diastolic blood pressure, TC = total cholesterol, HDL-c = high density
lipoprotein cholesterol, LDL-c = low density lipoprotein cholesterol, Trig = triglycerides,
QUICKI = quantitative insulin-sensitivity check index, hs-CRP = high sensitivity Creactive protein, sICAM-1 = soluble intercellular adhesion molecule-1, PAI-1 =
plasminogen activator inhibitor-1.
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Table 4.8 Comparison of Traditional and Emerging Cardiovascular Risk Factors among
Normal Weight and Obese African American Women
________________________________________________________________________
Normal Weight
Obese Group
(n = 21)
(n = 27)
t-Test P-Value
M (25th, 75th)*
M (25th, 75th)
________________________________________________________________________
Risk Factors

ASBP

103.5 (99.5, 110)

120.5 (115, 128.5) 16.807

0.0002

ADBP

67.5 (63, 72)

74.5 (70, 85)

13.103

0.0007

TC

182 (163, 197)

175 (163, 193)

0.2811

0.6065

HDL-c

58 (52, 65)

49 (38, 57)

7.2584

0.0100

LDL-c

114 (89, 126)

111 (90, 112)

0.0676

0.8040

Trig

56 (52, 66)

71 (59, 97)

5.6166

0.0225

Glucose

83 (81, 90)

89 (80, 102)

0.9563

0.3382

Hrs of moderate
wkly activity

18.0 (3.0, 73.0)

13.0 (0.0, 69.0)

0.8750

0.3597

Days/wk of moderate
activity

3.0 (0.0, 7.0)

3.0 (0.0, 7.0)

0.1967

0.6670

QUICKI

.26 (.256, .262)

.256 (.245, .263)

0.9563

0.3382

Hs-CRP

0.7 (0.3, 2.0)

4.1 (1.3, 10.4)

10.800

0.0020

Fibrinogen

332 (296, 388)

441 (354.5, 481)

7.0988

0.0109

E-selectin

17.5 (13.0, 28.2)

24 (15.5, 39.4)

1.1757

0.2884

sICAM-1

68.6 (54.8, 89.4)

95.3 (63.8, 150.1)

2.9397

0.0950

PAI-1
22.4 (13.8, 34.2)
25.1 (11.4, 51.6)
0.7439
0.3985
________________________________________________________________________
*M = Median (Interquatile range), ASBP = average systolic blood pressure, ADBP =
average diastolic blood pressure, TC = total cholesterol, HDL-c = high density
lipoprotein cholesterol, LDL-c = low density lipoprotein cholesterol, Trig = triglycerides,
QUICKI = quantitative insulin-sensitivity check index, hs-CRP = high sensitivity Creactive protein, sICAM-1 = soluble intercellular adhesion molecule-1, PAI-1 =
plasminogen activator inhibitor-1.
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Chi-square analysis provided an assessment of observed differences between the
proportions of cardiovascular risk factors in the two groups (normal weight and obese) to
ascertain their statistical significance. When there were less than 5 counts in a cell, Fisher
exact test was used as a more conservative measure. Table 4.9 depicts the frequency of
traditional and emerging cardiovascular risk factors in the normal weight and obese
groups. The normal weight and obese groups had a similar frequency of traditional risk
factors of diabetes, family history of cardiovascular disease, tobacco use, hypertension,
physical inactivity, and elevated total, LDL, and triglyceride levels. Low HDL-c was
more common in the obese group compared to the normal weight group.
With regards to the emerging cardiovascular risk factors, our results indicated that
the obese group exhibited a higher prevalence of elevated hs-CRP and fibrinogen markers
compared to the normal weight group (Table 4.9). The frequency of elevated PAI-1 was
similar between the normal weight and obese groups (42.86% vs, 48.15%). Chi-square
analysis for E-selectin, sICAM-1, and QUICKI was not performed because the norms for
these novel risk factors have not yet been established. For the purposes of classification,
the cutpoint for these values was E-selectin > 79.2 ng/ml, sICAM-1 > 320 ng/ml, and
QUICKI < 0.30 mg/dl. Abnormal E-selectin and sICAM-1 were infrequent; however, all
participants in both groups exhibited insulin resistance, as defined by a QUICKI level <
0.30.
Average Number of Risk Factors by Weight Group
The average number of risk factors an individual participant had was computed by
adding the number of risk factors divided by the sample population. The average number
of risk factors was 5.7 for the whole group. Compared to the normal weight group, the
obese group had significantly more risk factors (6.9. vs. 4.1, p < 0.05).
Average Number of Risk Factors by Physical Activity
We further determined the average number of risk factors based on physical
activity status by weight group and compared the groups. This was determined by the
total number of risk factors within each weight category divided by the total number in
their respective physical activity status categories. The obese participants who were
physically active had an average of 6.6 risk factors compared to 6.9 in those who were
inactive. Similarly, the normal weight participants who were active had an average of 3.9
risk factors compared to 4.3 in those who were physically inactive. While there was no
statistically significant difference within weight groups, we noted a statistically
significant difference between weight groups (p < 0.05).
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Table 4.9 Differences in Frequency of Cardiovascular Risk Factors between Weight
Groups
________________________________________________________________________
Risk Factors

Normal Weight
Obese Group
Chi-Square
P-Value
n (%)
n (%)
χ2
________________________________________________________________________
Diabetes

0

2 (7.41%)

1.8847

0.3897

Fm Hx CVD

13 (61.90%)

15 (55.56%)

0.1959

0.6580

Tobacco use

5 (23.81%)

7 (25.93%)

0.0282

0.8666

HTN

0

2 (7.41%)

11.7188

0.0029

TC

4 (19.05%)

5 (18.52%)

0.0022

0.9628

HDL-c

4 (19.05%)

14 (51.85%)

5.4236

0.0199

LDL-c

4 (19.05%)

4 (14.81%)

0.1524

0.6963

Trig

9 (42.86%)

2 (7.41%)

0.1411

0.7072

Physical inactivity
13 (61.90%)
(< 5days of
physical activity/wk)

22 (81.48%)

2.2924

0.1300

Hs-CRP

5 (23.81%)

17 (62.96%)

7.2940

0.0069

Fibrinogen

7 (33.33%)

20 (76.92%)

9.0295

0.0027

PAI-1

9 (42.86%)

13 (48.15%)

0.1332

0.7151

E-selectin

1 (4.76%)

2 (7.41%)

sICAM-1

0

2 (7.41%)

QUICKI
21 (100%)
27 (100%)
________________________________________________________________________
Fm Hx CVD = family history of cardiovascular disease, HTN = hypertension, TC = total
cholesterol, HDL-c = high density lipoprotein cholesterol, LDL-c = low density
lipoprotein cholesterol, Trig = triglyceride, hs-CRP = high sensitivity C = reactive
protein, PAI-1 = plasminogen activator inhibitor-1, sICAM-1 = soluble intercellular
adhesion molecule-1, QUICKI = quantitative insulin-sensitivity check index. n (%):
values represent abnormal levels of the risk factors.
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CHAPTER 5. DISCUSSION AND IMPLICATIONS
Discussion
Cardiovascular disease and obesity are major public health concerns of our times.
Women bear the highest prevalence of morbidity and mortality from cardiovascular
disease and African American women are the most affected. While there have been
multiple focused studies on either cardiovascular disease or obesity, only limited studies
have explored the interaction between obesity and cardiovascular disease risk factors in
women and much fewer studies have specifically looked at this unique population of
African American women. This study sought to explore the relationship between obesity
and the traditional and emerging cardiovascular risk factors in young African American
women with no previous history of cardiovascular disease. This chapter includes a
discussion of significant findings and compares study results to existing research. Study
limitations and recommendations for research, theory, and practice are also discussed.
The results show that both traditional and emerging cardiovascular disease risk
factors were more prevalent among obese than normal weight subjects. This difference
was statistically significant with regards to HDL-cholesterol (p = 0.02), hs-CRP (p =
0.01), and Fibrinogen (p = 0.002). These findings are similar to the results of the MultiEthnic Study of Atherosclerosis, which examined the relation of obesity in older
individuals 45 to 84 years old (Bild et al., 2005). However, that study looked at only
traditional risk factors. There are other studies that have similarly shown a higher
prevalence of emerging cardiovascular risk factors among obese young adults (Appel,
Harrell, & Davenport, 2005; Santos, Lopes, Guimaraes, & Barros, 2005). These findings
carry implications for clinical practice: Obese adults without clinical cardiovascular
disease may already have a clustering of both traditional and emerging cardiovascular
risk factors. Institution of early and aggressive preventive measures in this population
could delay or arrest progression to clinical cardiovascular disease.
The knowledge gained by conducting this descriptive correlation analysis could
provide health care providers with the tools they need to educate and inform women
about their risks for cardiovascular disease and help them develop strategies for disease
prevention. To reduce the high morbidity and mortality of cardiovascular disease among
African American women, regular cardiovascular disease screening and intervention
should be started in early adulthood. Contrary to prevailing belief that heart disease is
rare among women and highly unlikely in premenopausal women, health care providers
should be reeducated on the need for treating cardiovascular risk in young adults.
Prevalence of Traditional and Emerging Cardiovascular Risk Factors
The first research aim of this study focused on describing the prevalence of
traditional and emerging cardiovascular risk factors in African American women ages 18
to 45 who have no known history of cardiovascular disease. The results of our study
showed that this sample of African American women had a high prevalence of both
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traditional and emerging cardiovascular risk factors. They presented with varying degrees
of the traditional cardiovascular risk factors with physical inactivity (72.92%), family
history of cardiovascular disease (58.3%), low HDL-cholesterol levels (37.5%), and
smoking (25%) being highly prevalent. This finding is consistent with the rate reported
by De, Searles, and Haddad (2002) in their study on the prevalence of cardiac risk factors
in 187 women 45 years of age and younger undergoing angiography for evaluation of
undiagnosed chest pain, a high-risk group. The most prevalent risk factor they found for
all study participants was a family history of premature coronary artery disease (67%),
followed by smoking (55%), and dyslipidemia (55%). They further reported that younger
women with coronary artery disease had a higher prevalence of dyslipidemia, diabetes,
and smoking than those without coronary artery disease. Gurevitz, Jonas, Boyko,
Rabinowitz, and Reicher-Reiss (2000), in a similar study of women aged 50 and under,
observed that the most prominent risk factor was hyperlipidemia (60%), followed by a
family history of coronary artery disease (44%), systemic hypertension (40%), cigarette
smoking (31%), postmenopausal state (23%), and diabetes mellitus (21%), with
hyperlipidemia and postmenopausal state more prevalent in those with significant
coronary artery disease.
Compared to the American Heart Association (2008) Statistical Fact Sheets of
women of all ages, our study showed a higher prevalence of low HDL-cholesterol in our
selected population (37.5% , 6.9%). Hypertension prevalence was much lower among
study participants than what was reported by the American Heart Association (4.17% vs.
46.6%), while a difference was also noted in the rate of tobacco use (25% vs. 17.3%).
The Centers for Disease Control and Prevention analyzed data from the Behavioral Risk
Factor Surveillance System (BRFSS) for the period 1994-2004 and reported a prevalence
rate of leisure time physical inactivity among non-Hispanic black women at a rate of
33.9% while 72.92% of participants in this study reported they did not engage in
moderate physical activity five or more days per week.
With regards to the prevalence rates of the emerging cardiovascular risk factors, a
literature search revealed that prevalence rates were not routinely reported. This is not
surprising given the newness of most of these biomarkers and the lack of large studies to
determine normative values., However, the literature does indicate that biomarkers such
as hs-CRP, Fibrinogen, insulin resistance, PAI-1, E-selectin and sICAM-1 vary in their
levels among people of diverse ethnic identities particularly African Americans (Albert &
Ridker, 2006; Sumner et al., 2008).
Coronary artery inflammation is involved in all stages of atherosclerotic plaque
formation. Markers of systemic inflammation can predict future cardiovascular events in
healthy persons and patients with coronary artery disease (Wilson et al., 1998). Available
literature indicates that measurement of certain inflammatory markers can help identify
high-risk patients, monitor disease activity, and provide a therapeutic guide for reducing
the inflammatory component of the disease (Rosenson & Koenig, 2003).
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Relationships between Cardiovascular Risk Factors
The second aim of the study was to examine the relationship between BMI,
physical activity levels, and other traditional and emerging cardiovascular disease risk
factors in African American women. In the adult population, obesity is defined as a body
mass index (BMI) of 30 kg/m2 or higher (Flegal et al., 2002). BMI was calculated by
using the Center for Disease Control formula expressed as weight in kilograms divided
by the square of height in meters. Obesity and physical inactivity have long been
associated with increased risk of cardiovascular disease and are associated with
traditional risk factors such as diabetes, hypertension, and hyperlipidemia (Fung et al.,
2001) and these risk factors contribute to thousands of preventable deaths in the United
States (CDC, 1999). Women who are sedentary are twice as likely to develop
cardiovascular disease as women who engage in physical activity (CDC, 2007a).
Relationships between BMI, Physical Activity, and Blood Pressure
The findings from our study showed a positive association between BMI and
blood pressure as well as physical activity and blood pressure. The results of our study
showed a significant positive relationship between BMI and systolic blood pressure (r =
0.67, p < 0.0001). Our study also showed a significant positive relation between BMI and
diastolic blood pressure (r = 0.61, p = < 0.0001). A negative, non-significant association
was also noted between days spent per week in moderate levels of physical activity and
diastolic blood pressure (r = -0.24, p = 0.09). These findings suggest that high BMI and
low physical activity levels (means < 5 days of moderate physical activity weekly) tended
to result in elevated systolic and diastolic blood pressure levels. This finding is consistent
with reports from the American Heart Association, which suggests that excess body
weight increases your risk of high blood pressure. Scherrer et al. (1991) noted that a 20pound increase in body weight is associated with a 3.0-mmHg higher systolic and 2.3mmHg higher diastolic blood pressure. This translates into an estimated 12% increased
risk for coronary heart disease in obese individuals (Chobanian et al., 2003).
In another study, Staffileno, Minnick, Coke, & Hollenberg (2007) examined the
effect of lifestyle physical activity on blood pressure indices in sedentary AfricanAmerican women aged 18 to 45 years with prehypertension or untreated stage 1
hypertension. They reported a significant reduction in systolic and diastolic blood
pressures in women who engaged in physical activity (r = -0.620, p = 0.024). According
to the American Heart Association, the incidence of cardiovascular risk factors such as
high blood pressure, physical inactivity, and obesity are higher in African American
women than in Caucasian women (AHA, 2008; Hajjar & Kotchen, 2003).
Correlations between BMI, Physical Activity, and Diabetes
High blood glucose or diabetes is another risk factor for cardiovascular disease.
The obesity epidemic has led to an emerging epidemic of type 2 diabetes, and African
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American women have been severely affected by both conditions. The results from our
study showed a non-significant relationship between BMI and fasting blood glucose (r =
0.12, p = 0.41), and between the number of days per week that participants engaged in
moderate weekly physical activity and fasting blood glucose (r = 0.03, p = 0.87). Other
research studies have shown that obesity is a strong risk factor for diabetes in African
American women. Krishnan, Rosenberg, Djousse, Cupples, and Palmer (2007) examined
the association between BMI, abdominal obesity, and weight gain in African American
women with risk of type 2 diabetes. They reported that during an 8 year follow-up period
of 49,766 women from the Black Women’s Health Study, 2,472 incident cases of
diabetes occurred. Krishnan, Rosenberg, and Palmer (2008) further used data from
45,668 black women aged 21 to 69 years to estimate incidence rate ratios for type 2
diabetes by comparing various levels of physical activity and television watching. They
found that vigorous activity was inversely associated with type 2 diabetes risk (p <
0.0001). The associations between physical activity and diabetes risk have been assessed
by a number of prospective studies and clinical trials. The results from these studies
consistently indicate that regular physical activity during leisure time or daily life reduces
the risk of type 2 diabetes by 15 to 60% (Qi, Hu, & Hu, 2008).
Relationships between BMI, Physical Activity, and Insulin Resistance
There is growing knowledge regarding the effect of insulin resistance and
cardiovascular health. The findings of our study show a weak negative non-significant
relationship between BMI and QUICKI [used to calculate insulin sensitivity] (r = -0.12, p
= 0.41). Given that there was little variability in QUICKI values among participants, it is
not surprising that the relationship was weak. A similar association was found between
days of moderate physical activity that participants engaged in per week and insulin
resistance (r = -0.17, p = 0.23). Published research largely agrees with our findings. Even
though their study examined a cohort of urban, predominantly African American
adolescents, Snitker, Le, Hager, Caballero, and Black (2007) reported an association
between physical activity and body composition with insulin sensitivity in a community
sample of adolescents and noted that both body composition and physical activity were
independently associated with insulin sensitivity.
Correlations between BMI, Physical Activity, and Lipid Levels
Serum lipids and lipoproteins (such as HDL-cholesterol, LDL-cholesterol, total
cholesterol, and triglycerides) are metabolic risk factors most closely related to
atherosclerosis. The findings from this current study showed a weak relationship
between total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides and BMI and
days spent in moderate physical activity per week. Statistical significance was noted
between BMI and HDL-cholesterol as well as between BMI and triglycerides (r = -0.35,
p = 0.01; r = 0.30, p = 0.04). This finding is consistent with what has been reported in the
literature. Rodriguez-Arcos, Smith, and Waldron (2002) studied cross-sectionally the
distribution and predictors of lipids and lipoproteins in elderly subjects and reported that
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African Americans had a lower total/HDL-cholesterol ratio and triglyceride levels along
with higher HDL-cholesterol levels (p < 0.0001). Body mass index was a significant
independent predictor of total cholesterol (beta = 0.74, p < 0.001). Walker, Piers, Putt,
Jones, and O'Dea (1999) examined the impact of a 16-week walking program on the
metabolic risk profile of postmenopausal women. Even though the age category varies
from our study population, the findings are noteworthy. In the sample of 153 women,
they reported that increased physical activity promoted weight loss, reduced blood
pressure, decreased plasma triglyceride, total cholesterol, and LDL-cholesterol, but
increased HDL cholesterol concentrations (p < 0.0001).
Relationships between BMI, Physical Activity, and Tobacco Use
Tobacco use is another risk factor examined in our study. Some research
indicates that smoking behavior is related to other health behaviors, such as sedentary
lifestyle, body weight, and consumption of fast food. Larsson, Story, Perry, NeumarkSztainer, and Hannan (2007) examined how smoking may be related to dietary intake of
key nutrients, consumption of fast food, sedentary lifestyle, or weight status. They
reported that smoking frequency was inversely related to participating in team sports,
eating regular meals, and consuming healthful foods and nutrients. The result of our
study showed a non-significant relationship between BMI and tobacco use (r = 0.05, p =
0.65). Our findings also showed a negative, significant relationship between number of
days participants engaged in at least moderate physical activity per week and tobacco use
(r = -0.25, p = 0.05). This finding is congruent with the study conducted by Harrell,
Speilman, and Smith (1988) on cardiovascular risk factors and socioeconomic status in
1,945 African American and Caucasian women aged 23 to 53 years. They reported that
38.8% of the African American women were obese, 51.7% were inactive, and 31.2%
smoked. After controlling for income and education, African American women were
more than twice as likely as Caucasian women to be obese and to be inactive but were
only half as likely to smoke.
Correlations between BMI, Physical Activity, and Family History of CVD
Family history of CVD, though a non-modifiable risk factor for cardiovascular
disease, often interacts with obesity and physical inactivity to worsen the chances for the
development of cardiovascular disease. Risk factors tend to occur in families and are said
to be especially evident in children when an adult relative is obese. The literature noted
that weight gain occurs differently in men and women. Weight gain in men occurs mostly
later in life while the greatest weight gain in women occurs in the younger age groups
(Krauss, Winston, Fletcher, & Grundy, 1998). Though genetic factors play a role in the
etiology of obesity and even CVD, this was not the subject of our study and was not
explored. However, our findings showed no association between family history of CVD
and BMI (r = - 0.01; p = 0.93) and a non significant relationship between family history
of CVD and number days of moderate physical inactivity engaged in by our study
participants (r = 0.18; p = 0.16).
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Relationships between BMI, Physical Activity, and Inflammation
C-reactive protein (CRP) is one of the acute-phase proteins in inflammation. It
has been suggested that hs-CRP is an independent marker of the risk of cardiovascular
disease, though its predictive capacity remains controversial. The results from our study
showed a positive significant association between BMI and hs-CRP (r = 0.51, p =
0.0002). There was a weak positive though non-significant relationship between the
number of days participants engaged in moderate physical activity and hs-CRP (r = 0.12,
p = 0.41). These findings suggest that participants with higher BMI and those who did
not meet the recommended amounts of daily physical activity had abnormal levels of hsCRP. This finding is supported by previous research studies. Rawson et al. (2003)
conducted a longitudinal study examining the effects of BMI on both current and
previous-year physical activity on hs-CRP in 109 healthy men and women. They reported
that average BMI was correlated with current physical activity (r = 0.50, p < 0.001) but
was not related to previous-year physical activity levels which was assessed using the
Baecke questionnaire at baseline (r = 0.02, p = 0.89). Their data indicated that BMI but
not previous-year or current physical activity predicts hs-CRP. Previous studies have also
suggested an inverse relationship between physical activity and markers of inflammation
such as hs-CRP. Majka et al. (2009) examined a cross-sectional association between
physical activity and hs-CRP in White, Chinese, Black, and Hispanic participants
enrolled in the Multi-Ethnic Study of Atherosclerosis in 2000-2002. They reported that
hs-CRP was higher in women than men with black women having the highest hs-CRP
level while Chinese women had the lowest even after adjusting for BMI, smoking, LDLc, HDL-c, blood pressure, diabetes and the use of statin, antihypertensive and diabetes
medications (p = 0.044).
Correlations between Obesity, Physical Activity, and Thrombotic and Endothelial
Dysfunction Markers
According to prospective epidemiological studies, plasma fibrinogen is a newly
emerging risk factor for cardiovascular disease. The deleterious effects of this protein
seem to be mediated through its role in hemostasis, and the atherogenic process itself,
particularly at high levels. Findings from our current study showed a positive significant
relationship between BMI and plasma fibrinogen levels (r = 0.49, p = 0.0004) and a nonsignificant association between the number of days participants engaged in daily
moderate physical activity per week and plasma fibrinogen levels (r = 0.06, p = 0.67).
Mora, Lee, Buring, and Ridker (2006) studied the association of physical activity and
BMI alone with hs-CRP, fibrinogen, soluble intercellular adhesion molecule-1 (sICAM1), homocystein, low-and high-density lipoprotein (LDL and HDL) cholesterol, total
cholesterol, apolipoprotein A-1 and B-100, lipoprotein(a), and creatinine. The results of
their study indicated that lower levels of physical activity and higher levels of BMI were
independently associated (p for trend < .001), with adverse levels of nearly all lipid and
inflammatory biomarkers.
Soluble intercellular adhesion molecule-1 (sICAM-1) is a transmembrane protein
involved in the migration and adhesion of leukocytes to the vascular endothelium.
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Available knowledge suggests that elevated baseline sICAM-1 levels predict
cardiovascular disease. The findings from our study showed a positive significant
association between BMI and sICAM-1 (r = 0.33, p = 0.02). Similarly, we noted a
positive significant relationship between the number of days participants engaged in
moderate physical activity per week and sICAM-1 (r = 0.31, p = 0.03). In a prospective
evaluation of 23,984 apparently healthy women, Albert et al. (2008) found sICAM-1
levels were predictive of cardiovascular events that reflect coronary atherosclerotic
disease progression and vessel narrowing (p trend = 0.008).
Plasminogen activator inhibitor 1 is the primary physiological inhibitor of
plasminogen activation in vivo, and elevations in plasma PAI-1 appear to compromise
normal fibrin clearance mechanisms and promote thrombosis. Findings from our study
showed a non-significant positive association between BMI and PAI-1 (r = 0.21, p =
0.15) as well as a non-significant relationship between the number of days participants
engaged in moderate physical activity per week and PAI-1. These results are consistent
with findings reported by Solano, Perry, Wang, Ross, and Goldberg (2003), suggesting
that relationships reported in white populations differs in African-Americans. Solano et
al., (2003), in a cross-sectional study of overweight and obese premenopausal African
American and Caucasian women aged 19 to 53 years, examined the association of PAI-1
with visceral adiposity and other components of the metabolic syndrome. They found no
significant association between PAI-1 and any of these variables (BMI, visceral adipose
tissue, glucose, systolic blood pressure, diastolic blood pressure, triglyceride, HDL
cholesterol) in African American women, despite their findings of a strong association
between these metabolic variables and PAI-1 in Caucasian women. They concluded that
the lack of a metabolic relationship between visceral fat and PAI-1 extends in parallel
fashion to other components of the metabolic syndrome in pre-menopausal African
American women. With regards to insulin resistance, they also noted there were no
significant differences in PAI-1, insulin, glucose and HOMA IR values between the two
groups (Solano et al., 2003). Elevated concentrations of hemostatic variables such as
fibrinogen and PAI-1 have been found in both African American and Caucasian women
overweight/obese women (Perry, Wang, Goldberg, Ross, & Jackson, 2008).
Plasma E-selectin is expressed on activated endothelium. The pathogenesis of
atherosclerosis involve change to the vascular endothelium which produces numerous
substances involved in the regulation and maintenance of vascular integrity and the
homeostasis of the coagulation/fibrinolysis system. In this study of young AfricanAmerican women, a weak positive non-significant relationship between BMI and Eselectin (r = 0.21, p = 0.15) as well as a weak positive non-significant association
between the number of days participant spent in moderate physical activity per week and
E-selectin (r = 0.22, p = 0.13) was noted. Limited research exists on most of these
emerging cardiac risk factors. However, a review of available studies indicates sparse
information regarding the association between E-selectin, BMI, and physical activity.
Demerath, Towne, Blangero, and Siervogel (2001) examined cross-sectional
relationships between the concentrations of soluble adhesion molecules (sICAM-1,
sVCAM-1, pSelectin, and E-selectin) and smoking behavior, body composition, blood
pressure, serum lipids and physical activity in 592 healthy white men and women aged 18
to 82 years. They found that men had higher E-selectin than women (p < 0.0001). They
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concluded that the concentration of soluble CAMs, particularly sICAM-1 and E-selectin,
reflect the level of established CVD risk factors in apparently healthy men and women.
In summary, our findings are consistent with previous studies by Mora, Lee,
Buring, and Ridker (2006) and Solano et al. (2003), which found an association between
BMI, physical activity levels, and insulin resistance and fibrinogen levels. The
differences between our findings and studies that examined relationships between the
concentrations of endothelial dysfunction markers may be attributed to differences in
methodology and their use of a more diverse population with a broader spectrum of
weight categories.
Differences in Cardiovascular Risk Factors by Weight Groups
The third, and last, study aim compared traditional and emerging cardiovascular
risk factors among normal weight and obese African American women. Obesity
contributes to numerous and varied comorbid conditions. The increased incidence of
obesity has also contributed to significant increases in the prevalence of most, if not all,
cardiovascular disease risk factors including hypertension, dyslipidemia, insulin
resistance, and type 2 diabetes. Several studies (Diez-Roux, 1999; Flegal et al., 2002)
have reported that African Americans who are obese have a greater chance of having
high blood pressure, diabetes, and high blood levels of triglycerides and cholesterol than
blacks who are not obese and these conditions increase the risk of developing
cardiovascular disease. This section will examine the differences in cardiovascular risk
factors between obese and normal weight African American women.
Regardless of weight, young African American women who participated in the
study had a high prevalence of traditional and emerging cardiovascular disease risk
factors. Obese participants exhibited a clustering of both the traditional and emerging
cardiovascular risk factors with individual obese participants having an average of 6.9
risk factors compared to 4.1 in the normal weight group. The obese group also tended to
have mean values toward the cutpoints supporting the negative effect of weight on these
other cardiovascular risk factors (Table 4.7). Statistically significant differences in the
frequency of cardiovascular risk factors between the two weight groups were noted in
only three of the risk factors: HDL-cholesterol (p = 0.01), hs-CRP (p = 0.00), and
fibrinogen (p = 0.00), although the prevalence rates for the other cardiovascular disease
risk factors was higher or similar between weight groups. Body weight or BMI did not
seem to make a difference in terms of the lipid profile.
Several previous studies have examined the association of cardiovascular risk
factors to body weight. The Coronary Artery Risk Development in Young Adults
(CARDIA) and the Atherosclerosis Risk in Communities (ARIC) studies investigated the
relationship between obesity and cardiovascular disease in African Americans (Folsom et
al., 1991). The CARDIA study examined the association between behavioral and
demographic factors and body size in over 2800 African American and white adults who
were between the ages of 18 and 30 (Burke et al., 1992), while the ARIC study included
15,803 African Americans and white adults aged 45 to 64. In these studies, body weight,
67

height, waist size, blood pressure, and blood sugar levels, and cholesterol were measured.
The authors found that weight gain was more common among black women than white
women and among black men than white men. Obesity in blacks was associated with
higher than normal blood pressure and higher blood glucose and cholesterol levels.
Diabetes was more common among blacks who were obese than among those who were
thin. The lower prevalence of hypertension and diabetes seen in the women who
participated in the current study may be partially attributed to their younger age. While
not statistically significant, only the obese women in the current study had hypertension
and diabetes. The results show that both traditional and emerging cardiovascular disease
risk factors were more prevalent among the obese than normal weight subjects. This
difference was statistically significant with regards to HDL-cholesterol (p = 0.02), hsCRP (p = 0.01), and fibrinogen (p = 0.002). These findings are similar to the results of
the Multi-Ethnic Study of Atherosclerosis, which examined the relation of obesity in
older men and women from diverse ethnic identities – White, African American,
Hispanic, and Asian aged 45 to 84 years old (Bild et al., 2005). However, their study
looked at only traditional risk factors. There are other studies that have similarly shown a
higher prevalence of emerging cardiovascular risk factors among obese young adults
(Appel et al., 2005; Santos et al., 2005).
In studies examining children and young adults ages 5 to 24 years, Gustat,
Srinivasan, Elkasabany, and Berenson (2002), of the Bogalusa Heart Study, examined the
relation of obesity to cardiovascular risk factors. They found a high prevalence of
elevated systolic blood pressure, fasting insulin, and LDL-cholesterol, and low HDLcholesterol among the obese children and young adults. Although this age category
differs somewhat from our study population, the findings underscore the point that
obesity adversely affects cardiovascular disease risk factors throughout the lifespan.
Similarly, Nelson et al. (2002) examined a sample of low-income African
American and white women ≥ 50 years old to assess whether obesity occurs
concomitantly with several coronary heart disease risk factors (diabetes, hypertension,
hypercholesterolemia, low high-density lipoprotein cholesterol (HDL-C), and estimated
the 10-year risk for coronary heart disease in the North Carolina WISEWOMAN (Well
Integrated Screening and Evaluation for Women Across the Nation) Study sample. The
results of their study showed that African American women had significantly higher
BMIs, systolic blood pressure, diastolic blood pressure, and HDL-C levels than white
women. The prevalence of self-reported diabetes was also significantly greater for
African American women. They further reported that obese African American women
were more likely to have diabetes and high blood pressure than the non-obese African
American women. In contrast, our sample of obese African American women had a low
prevalence of diabetes and hypertension which was similar to that found in the non-obese
group. Cowie et al. (2006) reported the prevalence rates of self-reported diabetes in a
nationally representative sample of African American women ages 20 to 39 and 40 to 59
were 4.7% and 12.7%, respectively. Given that the mean age of participants in the current
study was 31, the overall prevalence rate of 4.7% is consistent with findings from the
National Health and Nutrition Survey.
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However, impaired fasting glucose was presented in 10.4% of obese participants
and 6.3% of normal weight individuals. It is recognized that type 2 diabetes is
characterized by insulin resistance. Initially, hyperinsulinemia occurs in an attempt to
maintain serum glucose levels. Over time, these effects are insufficient to maintain
normoglycemia and prediabetes develops, presenting as either elevated fasting glucose
and/or elevated post-parandial glucose levels. Further deterioration in insulin sensitivity
or beta-cell function results with progression to diabetes mellitus. The literature suggests
that impaired fasting glucose (prediabetes) also increases risk for cardiovascular disease.
Cowie et al. (2006) reported prevalence rates of prediabetes based on fasting blood
glucose levels in adults participating in the NHANES study. African American women
ages 20-39 and 40-59 of 8.4% and 15.9% respectively which is consistent with the 16.7%
overall prevalence rate of our sample. The mean age of the current study sample was 31.
All the participants in our study had insulin resistance irrespective of their weight
category. This finding is inconsistent with what has been reported in the literature. The
difference may be as a result of a different protocol for measuring insulin resistance or
the use of cutpoints that have been used to predict prediabetes in obese adolescents. The
association between adiposity and insulin resistance has been reported in children and
adults. Weight loss was associated with a decrease in insulin concentration and an
increase in insulin sensitivity (Arslanian, Suprasongsin, & Janosky, 1997). African
Americans have been reported to have the greater prevalence of insulin resistance,
hypertension, diabetes and obesity and these may contribute to vascular disease (Falkner,
Hulman, Tannenbaum, & Kushner, 1990).
Gustat et al. (2002) examined the relation of self-rated measures of physical
activity to multiple risk factors of insulin resistance syndrome (IRS) in African American
and white young adults aged 20 to 38 years enrolled in the Bogalusa Heart Study. They
found an inverse relationship between leisure-time activity and mean number of risk
factors whereas a positive relationship was seen with hours of inactivity (p < 0.001).
Moderate to very active individuals versus inactive individuals had a reduced relative risk
of having > or = 3 risk factors determined by waist circumference, blood pressure, total to
high-density lipoprotein cholesterol ratio, and insulin resistance index showed a positive
trend with hours of inactivity (p < 0.01). Thus, the low levels of physical activity reported
by individuals, with the majority of their activity being moderate or less intense, may
contribute to the insulin resistance found in this sample of young African Americans.
Data from the 1999-2004 National Health and Nutrition Examination Survey
examined whether obesity’s association with novel cardiovascular risk factors such as Creactive protein varies by race. Wee et al. (2008) noted an association between obesity
and CRP in African Americans. Research investigating the role of obesity in inducing
upregulation of adhesion molecules such as sICAM-1, VCAM-1, and E-selectin levels in
40 obese and 30 non-obese patients with type 2 diabetes (Matsumoto et al., 2002)
suggested that sICAM-1 and VCAM-1 levels did not differ significantly between obese
and non-obese patients. However, serum concentrations of E-selectin levels were
significantly higher in obese than in non-obese patients. This report was further supported
by Nijhuis et al. (2007) in their investigation of the role of obesity in endothelial cell
activation following long term weight loss after bariatric surgery. They noted that despite
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substantial weight loss during the first six months post-bariatric surgery, E-selectin levels
decreased while sICAM-1 and sVCAM-1 plasma levels did not decrease significantly.
These reports differ from our study finding partly because there is no defined normal
reference for these novel risk markers yet.
Increased levels of risk factors such as PAI-1 and fibrinogen have also been
associated with increased risk for cardiovascular disease. The literature is equally clear
on the relationship between plasma PAI-1 and obesity as well as between fibrinolysis and
obesity. Studies performed in obese and normal weight subjects suggested that obese
subjects had higher plasma concentrations of PAI-1 as compared to non-obese controls
(Hong, Pedersen, Egberg, & de Faire, 1997). Similar studies show that obesity may
account for higher concentrations of fibrinogen with plasma levels of fibrinogen
correlating with central obesity independently of metabolic factors (Mertens & Van Gaal,
2002).
Strengths and Limitations
The strength of this study is rooted in its uniqueness in that it sought to provide
much needed information on the association between obesity and cardiovascular disease
risk factors in African American women. Data on this population have been sparse
despite African Americans having the highest rate of cardiovascular morbidity and
mortality. The study not only expands knowledge about this understudied population but
also provides direction for policy, clinical practice, and future research. The focus of the
study on African American women aged 18 to 45 helps to illustrate the potential benefits
of early screening in a population that would otherwise be considered low-risk. It has
been recognized that though symptomatic cardiovascular disease is less common in premenopausal women, the process of atherosclerosis starts long before menopause and
earlier intervention might be useful in reducing the long-term morbidity and mortality
associated with cardiovascular disease.
This study is not without limitations. The cross-sectional descriptive correlational
design allows researchers to gather data from one point in time. This does not reflect the
totality of the participants’ experiences hence the findings, though valid, may not
necessarily represent the influence of body weight on cardiovascular disease risk factors
over time. A longitudinal research study might be a better tool in assessing the long-term
relationship between body weight and cardiovascular disease risk factors. Another
inherent limitation is the small sample size and lack of regional and cultural diversity. All
the participants were recruited from two adjoining states from the mid-south, and the
findings may not be characteristic of other African American women from other parts of
the country. The use of self-reporting instruments to elicit information regarding illicit
drug use, smoking history, and even physical activity levels is another limitation of the
study due to potential recall bias and under reporting. The emerging cardiovascular
disease risk factors are by definition novel without established cut-points which raises
questions on the validity of cut-points used in this study.
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Relation of Study Results to Conceptual Framework
This study examined the relationship between obesity and the traditional and
emerging cardiovascular risk factors. Cardiac risk factors are good indicators of an
individual’s overall risk of developing heart disease. The conceptual model (see Figure
1.1) depicts major risk factors for cardiovascular disease and their interrelationship.
Obesity is not just one of the traditional modifiable risk factors for cardiovascular disease
but is also associated with increased prevalence of other risk factors such as diabetes,
hypertension, and dyslipidemia. The findings of our study show a higher prevalence of
physical inactivity, tobacco use, dyslipidemia, and diabetes among obese participants
with statistical significance noted in only HDL-cholesterol levels.
While our study had controlled for age, gender, and ethnicity or race (all nonmodifiable traditional cardiovascular risk factors), it is, however, a known fact that higher
rates of coronary heart disease have been reported among men compared with women
with increased risk of stroke among African Americans. It is equally well established that
advancing age is an independent risk factor for cardiovascular disease as the risk of
stroke is said to double every decade after age 55. The result of our study shows no
statistical difference between the obese and normal weight participants who reported a
family history of cardiovascular disease. These non-modifiable risk factors have been
known to affect or influence development of the modifiable risk factors.
Emerging risk factors such as fibrinogen, triglycerides, insulin resistance, hsCRP, PAI-1, sICAM-1, and E-selectin are novel risk factors that occur in obese people
either correlate with traditional cardiovascular risk factors or predict subsequent
cardiovascular events. Our findings showed that these risk factors were elevated in obese
participants with statistical significance noted in hs-CRP and fibrinogen levels.
Cardiovascular risk and outcome are affected by socio-cultural factors. More of
the participants in the obesity group reported having high school education or lower and
earned less annual household income compared to the normal weight group. Even though
we did not evaluate the health belief systems or their health seeking behaviors, we
ascertained that all the study participants had health insurance coverage. Griffith, Moy,
Reischl, and Dayton (2006) described five models that explain disparities in
cardiovascular disease outcomes in African American women. Racial-genetic, healthbehavior, socioeconomic, psychosocial stress, and structural-constructivist models were
identified as possible explanations for the observed disparities in cardiovascular disease
burden and outcome among different racial and ethnic groups. It is a known fact that
inherent biological differences among ethnic groups are the determinants of disease
burden and outcomes. This suggests that there are differences between racial and ethnic
groups in the distribution of individual health behaviors such as physical activity and
tobacco use. Cultural differences are thought to explain disparities in health outcome with
socioeconomic status believed to be a primary determinant of health and disease while
psychosocial stress model attributes health disparities to the discrimination and racism
experienced by ethnic minorities who often suffer as a result of the power structure and
centuries of exploitation, discrimination and racism. This explains the association
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between socio-cultural factors and the emerging risk factors as well as the traditional
non-modifiable cardiac risk factors.
Practice and Policy Implications
These findings carry implications for clinical practice: obese adults without
clinical cardiovascular disease may already have a clustering of both traditional and
emerging cardiovascular risk factors. Institution of early and aggressive preventive
measures in this population could delay or arrest progression to clinical cardiovascular
disease.
The knowledge gained by conducting this descriptive correlation analysis could
provide health care providers with the tools they need to educate and inform women
about their risks for cardiovascular disease and help them develop strategies for disease
prevention. To reduce the high morbidity and mortality of cardiovascular disease among
African American women, regular cardiovascular disease screening and intervention
should be started in early adulthood. Contrary to prevailing beliefs that heart disease is
rare among women and highly unlikely in premenopausal women, health care providers
should be reeducated on the need of cardiovascular risk assessment in young adults.
A collaborative effort between health care professionals and members of minority
communities is necessary to provide effective outcomes that increase physical activity in
this population. African American women like other people should be encouraged to seek
regular medical evaluation with detailed screening for risk factors even when
asymptomatic as this may represent the best opportunity to limit the devastating effects of
cardiovascular disease. They should also be encouraged to be proactive in advocating for
their health. City and state governments should embark on a variety of educational and
public awareness activities to educate the citizenry particularly ethnic minorities about
their cardiovascular risk factors by helping them to learn more about their risk for heart
disease so they can take action to lower the risk.
The indisputable benefit of early screening and primary prevention should compel
insurance payers to compensate clinicians who provide such care. In line with several
study findings (Chopra, Choksi, & Cavusoglu, 2007; Ridker et al., 2008), it could be
beneficial to treat asymptomatic individuals some of whom may have prehypertension or
impaired glucose tolerance with several anti-inflammatory medications (such as statins)
that are currently reserved for those already determined to have disease. The benefits of
this should be carefully weighed against the risks in these women of child bearing age.
Recommendations for Future Research
The findings of this descriptive correlational study provide various opportunities
for future research into the cardiovascular health of African American women. A
longitudinal study that examines the association between obesity and the traditional and
emerging cardiovascular disease risk factors is highly recommended. Such a study would
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provide more insight into the complex mechanisms at work in cardiovascular disease,
particularly with risk stratification in this vulnerable population. Also a longitudinal study
of these women to determine their outcomes overtime and if and how these risk factors
change to examine the natural history of these risk markers would be of additional
benefit. Besides conducting a longitudinal study, it would be equally beneficial to sample
a larger population of African American women across different regions of the United
States for a more representative sample. Such a diverse population would make
generalization of the study sample feasible. Another suggestion for future research is to
examine obese persons who engage in recommended amounts of physical activity and
those who do not to determine if there is a difference in the levels of the risk factors
between the groups. This is because there is a growing thought that obese persons who
are physically fit are less likely to manifest the risk factors for cardiovascular disease.
Although an examination of possible barriers to cardiovascular health was beyond the
scope of this study, it is recommended for further research of this population. Finally, it
would make much sense to conduct similar research on women of other ethnicities to
determine if differences exist in the manifestation of these risk factors for heart disease.
Conclusions
Obesity is highly prevalent among African American women. We found that the
coronary heart disease risk factors that often occur with obesity clustered in the African
American women, whether they were obese or not, whereas more risk factors occurred in
the presence of obesity. Among African American women there was no statistically
significant difference for the clustering of triglycerides, LDL-cholesterol, total
cholesterol, physical inactivity, smoking, hypertension, PAI-1, E-selectin, and sICAM-1
between obese and non-obese women. This knowledge is relevant given the fact that
literature is scarce regarding the prevalence of the emerging cardiovascular risk factors in
African American women. Moreover, previous studies have reported a relationship
between obesity and cardiovascular disease risk factors among ethnic minorities.
The result of our study is alarming, given the increased national awareness of
cardiovascular risk among the United States general population. The continued lifestyle
that excludes regular physical activity and the prevalence of both the traditional and
emerging risk factors for heart disease among our study population is a public health
concern. Targeted media campaigns and intervention programs should be directed to this
at-risk population in order to promote healthy lifestyle change within their financial and
time constraints. Health care providers should engage in widespread cardiovascular
disease prevention education programs that are culturally relevant to this underserved
population. Governmental intervention is needed to increase access to care, support
health promotion information, and provide resources to aid low-income African
American women who may lack awareness of the importance of cardiovascular disease
risk prevention and management. Given the advancement in technology, medical
breakthroughs, and increased scientific knowledge, one should hope that cardiovascular
disease will no longer be the leading cause of death among women in the United States.
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